Document:

Exhibit 4.2

 

EXECUTION VERSION

 

 

 

REGISTRATION RIGHTS AGREEMENT

 

Dated as of September 11, 2014

 

Among

 

Omega
Healthcare Investors, Inc.

 

and

 

THE GUARANTORS NAMED HEREIN

 

as Issuers,

 

and

 

J.P. MORGAN
SECURITIES LLC

MERRILL
LYNCH, PIERCE, FENNER & SMITH INCORPORATED

CREDIT AGRICOLE
SECURITIES (USA) INC.

RBS SECURITIES
INC.

 

On behalf of the several Initial Purchasers

 

4.50% Senior Notes due 2025

 

    	 

    	 

    

 

TABLE OF CONTENTS

 

	 	 	Page
	 	 	 
	1.	Definitions	1
	 	 	 
	2.	Exchange Offer	5
	 	 	 
	3.	Shelf Registration	9
	 	 	 
	4.	Additional Interest	11
	 	 	 
	5.	Registration Procedures	12
	 	 	 
	6.	Registration Expenses	22
	 	 	 
	7.	Indemnification and Contribution.	23
	 	 	 
	8.	Rules 144 and 144A	26
	 	 	 
	9.	Underwritten Registrations	27
	 	 	 
	10.	Miscellaneous	27

 

    	-i-

    	 

    

 

REGISTRATION RIGHTS AGREEMENT

 

This Registration Rights Agreement (this
“Agreement”) is dated as of September 11, 2014, among OMEGA HEALTHCARE INVESTORS, INC., a Maryland corporation
(the “Company”), the subsidiaries of the Company listed on the signature pages hereto (collectively, and together
with any entity that in the future executes a supplemental indenture pursuant to which such entity agrees to guarantee the Notes
(as hereinafter defined), the “Guarantors,” and together with the Company, the “Issuers”),
J.P. MORGAN SECURITIES LLC, MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED, CREDIT AGRICOLE SECURITIES (USA) INC. AND
RBS SECURITIES INC., collectively on behalf of the several initial purchasers (collectively, the “Initial Purchasers”)
listed on Schedule 1 to the Purchase Agreement (as defined below).

 

This Agreement is entered into in connection
with the Purchase Agreement by and among the Issuers and J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith
Incorporated, Credit Agricole Securities (USA) Inc. and RBS Securities Inc., collectively on behalf of the Initial Purchasers,
dated as of September 4, 2014 (the “Purchase Agreement”), which provides for, among other things, the sale
by the Company to the Initial Purchasers of $250,000,000 aggregate principal amount of the Company’s 4.50% Senior Notes
due 2025 (the “Notes”) guaranteed on a senior basis by the Guarantors (the “Guarantees”).
In order to induce the Initial Purchasers to enter into the Purchase Agreement, the Issuers have agreed to provide the registration
rights set forth in this Agreement for the benefit of the Initial Purchasers and any subsequent holder or holders of the Notes.
The execution and delivery of this Agreement is a condition to the Initial Purchasers’ obligation to purchase the Notes
under the Purchase Agreement.

 

The parties hereby agree as follows:

 

		1.	Definitions

 

As used in this Agreement, the following
terms shall have the following meanings:

 

Additional
Interest:  See Section 4(a) hereof.

 

Additional
Notes:  shall have the meaning ascribed thereto in the Indenture.

 

Advice:  See
the last paragraph of Section 5 hereof.

 

Agreement:  See
the introductory paragraphs hereto.

 

Applicable
Period:  See Section 2(b) hereof.

 

    	 

    	 

    

 

Application:  See
Section 7(a) hereof.

 

Business
Day:  Any day that is not a Saturday, Sunday or a day on which banking institutions in New York are authorized
or required by law to be closed.

 

Company:  See
the introductory paragraphs hereto.

 

Effectiveness
Date:  With respect to (i) the Exchange Offer Registration Statement, the 270th day after the Issue
Date and (ii) any Shelf Registration Statement, the 60th day after the Filing Date with respect thereto; provided,
however, that if the Effectiveness Date would otherwise fall on a day that is not a Business Day, then the Effectiveness
Date shall be the next succeeding Business Day.

 

Effectiveness
Period:  See Section 3(a) hereof.

 

Event
Date:  See Section 4(b) hereof.

 

Exchange
Act:  The Securities Exchange Act of 1934, as amended, and the rules and regulations of the SEC promulgated
thereunder.

 

Exchange
Notes:  See Section 2(a) hereof.

 

Exchange
Offer:  See Section 2(a) hereof.

 

Exchange
Offer Registration Statement:  See Section 2(a) hereof.

 

FINRA:  Financial
Industry Regulatory Authority, Inc.

 

Filing
Date:  (A) If no Registration Statement has been filed by the Company pursuant to this Agreement, the
220th day after the Issue Date; and (B) in any other case (which may be applicable notwithstanding the consummation of the
Exchange Offer), the 60th day after the delivery of a Shelf Notice as required pursuant to Section 2(c) hereof; provided,
however, that if the Filing Date would otherwise fall on a day that is not a Business Day, then the Filing Date shall be
the next succeeding Business Day.

 

Guarantees:  See
the introductory paragraphs hereto.

 

Guarantors:  See
the introductory paragraphs hereto.

 

Holder:  Any
holder of a Registrable Note or Registrable Notes.

 

Indenture:  The
Indenture, dated as of September 11, 2014, by and among the Company, the Guarantors and U.S. Bank National Association, as Trustee,
pursuant to which

 

    	-2-

    	 

    

 

the Notes are being issued, as amended or
supplemented from time to time in accordance with the terms thereof.

 

Information:  See
Section 5(o) hereof.

 

Initial
Purchasers:  See the introductory paragraphs hereto.

 

Initial
Shelf Registration:  See Section 3(a) hereof.

 

Inspectors:  See
Section 5(o) hereof.

 

Issue
Date:  September 11, 2014, the date of the original issuance of the Notes.

 

Issuers:  See
the introductory paragraphs hereto.

 

Notes:  See
the introductory paragraphs hereto.

 

Participant:  See
Section 7(a) hereof.

 

Participating
Broker-Dealer:  See Section 2(b) hereof.

 

Person:  An
individual, trustee, corporation, partnership, limited liability company, joint stock company, trust, unincorporated association,
union, business association, firm or other legal entity.

 

Private
Exchange:  See Section 2(b) hereof.

 

Private
Exchange Notes:  See Section 2(b) hereof.

 

Prospectus:  The
prospectus included in any Registration Statement (including, without limitation, any prospectus subject to completion and a prospectus
that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance
upon Rule 430A under the Securities Act and any “issuer free writing prospectus” as defined in Rule 433 under
the Securities Act), as amended or supplemented by any prospectus supplement, and all other amendments and supplements to the
Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by reference
in such Prospectus.

 

Purchase
Agreement:  See the introductory paragraphs hereof.

 

Records:  See
Section 5(o) hereof.

 

Registrable
Notes:  Each Note (and the related Guarantees) upon its original issuance and at all times subsequent thereto,
each Exchange Note (and the related Guarantees)

 

    	-3-

    	 

    

 

as to which Section 2(c)(iv) hereof
is applicable upon original issuance and at all times subsequent thereto and each Private Exchange Note (and the related Guarantees)
upon original issuance thereof and at all times subsequent thereto, until, in each case, the earliest to occur of (i) a Registration
Statement (other than, with respect to any Exchange Note as to which Section 2(c)(iv) hereof is applicable, the Exchange
Offer Registration Statement) covering such Note, Exchange Note or Private Exchange Note has been declared effective by the SEC
and such Note, Exchange Note or such Private Exchange Note, as the case may be, has been disposed of in accordance with such effective
Registration Statement, (ii) such Note has been exchanged pursuant to the Exchange Offer for an Exchange Note or Exchange
Notes (and the related Guarantees) that may be resold without restriction under the Securities Act, (iii) such Note, Exchange
Note or Private Exchange Note (and the related Guarantees), as the case may be, ceases to be outstanding for purposes of the Indenture
or (iv) such Note or Private Exchange Note, as the case may be, shall have been otherwise transferred by the holder thereof and
a new security not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent disposition
of such new security shall not require registration or qualification under the Securities Act.

 

Registration
Statement:  Any registration statement of the Company that covers any of the Notes, the Exchange Notes or
the Private Exchange Notes (and the related Guarantees) filed with the SEC under the Securities Act, including the Prospectus,
amendments and supplements to such registration statement, including post-effective amendments, all exhibits, and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement.

 

Regulatory
Requirements:  See the last paragraph of this Section 1.

 

Rule
144:  Rule 144 under the Securities Act.

 

Rule
144A:  Rule 144A under the Securities Act.

 

Rule
405:  Rule 405 under the Securities Act.

 

Rule
415:  Rule 415 under the Securities Act.

 

Rule
424:  Rule 424 under the Securities Act.

 

SEC:  The
U.S. Securities and Exchange Commission.

 

Securities
Act:  The Securities Act of 1933, as amended, and the rules and regulations of the SEC promulgated thereunder.

 

Shelf
Notice:  See Section 2(c) hereof.

 

Shelf
Registration:  See Section 3(b) hereof.

 

    	-4-

    	 

    

 

Shelf
Registration Statement:  Any Registration Statement relating to a Shelf Registration.

 

Shelf
Suspension Period:  See Section 3(a) hereof.

 

Subsequent
Shelf Registration:  See Section 3(b) hereof.

 

TIA:  The
Trust Indenture Act of 1939, as amended.

 

Trustee:  The
trustee under the Indenture and the trustee (if any) under any indenture governing the Exchange Notes and Private Exchange Notes
(and the related Guarantees).

 

Underwritten
registration or underwritten offering:  A registration in which securities of the Company are sold to an
underwriter for reoffering to the public.

 

Except as otherwise specifically provided,
all references in this Agreement to acts, laws, statutes, rules, regulations, releases, forms, no-action letters and other regulatory
requirements (collectively, “Regulatory Requirements”) shall be deemed to refer also to any amendments thereto
and all subsequent Regulatory Requirements adopted as a replacement thereto having substantially the same effect therewith; provided
that Rule 144 shall not be deemed to amend or replace Rule 144A.

 

		2.	Exchange Offer

 

(a)         Unless the Exchange Offer would violate
applicable law or any applicable interpretation of the staff of the SEC, the Issuers shall use commercially reasonable efforts
to file with the SEC, no later than the Filing Date, a Registration Statement (the “Exchange Offer Registration Statement”)
on an appropriate registration form with respect to a registered offer (the “Exchange Offer”) to exchange any
and all of the Registrable Notes for a like aggregate principal amount of debt securities of the Company (the “Exchange
Notes”), guaranteed on a senior basis by the Guarantors, that are identical in all material respects to the Notes, except
that (i) the Exchange Notes shall contain no restrictive legend thereon and (ii) interest thereon shall accrue from
the last date on which interest was paid on the Notes or if no such interest has been paid, from the Issue Date, and which
are entitled to the benefits of the Indenture or a trust indenture which is identical in all material respects to the Indenture
(other than such changes to the Indenture or any such identical trust indenture as are necessary to comply with the TIA) and which,
in either case, conforms to the requirements necessary for qualification under the TIA. The Exchange Offer shall comply with all
applicable tender offer rules and regulations under the Exchange Act and other applicable laws. The Issuers shall (x) use
commercially reasonable efforts to cause the Exchange Offer Registration Statement to be declared effective under the Securities
Act on or before the Effectiveness Date; (y) keep the Exchange Offer open for at least 30 days (or longer if required by
applicable law) after the

 

    	-5-

    	 

    

 

date that notice of the Exchange Offer is
mailed to Holders; and (z) consummate the Exchange Offer on or prior to the 360th day following the Issue Date.

 

Each Holder (including, without limitation,
each Participating Broker-Dealer) who participates in the Exchange Offer will be required to represent to the Issuers in writing
(which may be contained in the applicable letter of transmittal) that:  (i) any Exchange Notes acquired in exchange
for Registrable Notes tendered are being acquired in the ordinary course of business of the Person receiving such Exchange Notes,
whether or not such recipient is such Holder itself; (ii) at the time of the commencement or consummation of the Exchange
Offer neither such Holder nor, to the actual knowledge of such Holder, any other Person receiving Exchange Notes from such Holder
has an arrangement or understanding with any Person to participate in the “distribution” (within the meaning of the
Securities Act) of the Exchange Notes in violation of the provisions of the Securities Act; (iii) neither the Holder nor,
to the actual knowledge of such Holder, any other Person receiving Exchange Notes from such Holder is an “affiliate”
(as defined in Rule 405) of the Company or, if it is an affiliate of the Company, it will comply with the registration and
prospectus delivery requirements of the Securities Act to the extent applicable and will provide information to be included in
the Shelf Registration Statement in accordance with Section 5 hereof in order to have their Notes included in the Shelf Registration
Statement and benefit from the provisions regarding Additional Interest in Section 4 hereof; (iv) neither such Holder nor,
to the actual knowledge of such Holder, any other Person receiving Exchange Notes from such Holder is engaging in or intends to
engage in a distribution of the Exchange Notes; and (v) if such Holder is a Participating Broker-Dealer, such Holder has
acquired the Registrable Notes as a result of market-making activities or other trading activities and that it will comply with
the applicable provisions of the Securities Act (including, but not limited to, the prospectus delivery requirements thereunder)
in connection with any resale of the Exchange Notes.

 

Upon consummation of the Exchange Offer in
accordance with this Section 2, the provisions of this Agreement shall continue to apply, mutatis mutandis,
solely with respect to Registrable Notes that are Private Exchange Notes, Exchange Notes as to which Section 2(c)(iv) is
applicable and Exchange Notes held by Participating Broker-Dealers, and the Company shall have no further obligation to register
Registrable Notes (other than Private Exchange Notes and Exchange Notes as to which clause 2(c)(iv) hereof applies) pursuant
to Section 3 hereof.

 

No securities other than the Exchange Notes
shall be included in the Exchange Offer Registration Statement or exchange notes and related guarantees issuable in respect of
Additional Notes.

 

(b)         The Issuers shall include within the
Prospectus contained in the Exchange Offer Registration Statement a section entitled “Plan of Distribution,” in the
form attached hereto as Exhibit A or as otherwise, reasonably acceptable to the Initial Purchasers, which shall contain a summary
statement of the positions taken or policies made by the staff

 

    	-6-

    	 

    

 

of the SEC with respect to the potential
“underwriter” status of any broker-dealer that is the “beneficial owner” (as defined in Rule 13d-3
under the Exchange Act) of Exchange Notes received by such broker-dealer in the Exchange Offer (a “Participating Broker-Dealer”),
whether such positions or policies have been publicly disseminated by the staff of the SEC or such positions or policies represent
the prevailing views of the staff of the SEC. Such “Plan of Distribution” section shall also expressly permit, to
the extent permitted by applicable policies and regulations of the SEC, the use of the Prospectus by all Persons subject to the
prospectus delivery requirements of the Securities Act, including, to the extent permitted by applicable policies and regulations
of the SEC, all Participating Broker-Dealers, and include a statement describing the means by which Participating Broker-Dealers
may resell the Exchange Notes in compliance with the Securities Act.

 

The Issuers shall use commercially reasonable
efforts to keep the Exchange Offer Registration Statement effective and to amend and supplement the Prospectus contained therein
in order to permit such Prospectus to be lawfully delivered by all Persons subject to the prospectus delivery requirements of
the Securities Act for such period of time as is necessary to comply with applicable law in connection with any resale of the
Exchange Notes; provided, however, that such period shall not be required to exceed 90 days or such longer period
if extended pursuant to the last paragraph of Section 5 hereof (the “Applicable Period”).

 

If, prior to consummation of the Exchange
Offer, the Initial Purchasers hold any Notes acquired by them that have the status of an unsold allotment in the initial distribution,
the Issuers, upon the request of the Initial Purchasers, shall simultaneously with the delivery of the Exchange Notes issue and
deliver to the Initial Purchasers, in exchange (the “Private Exchange”) for such Notes held by any such Holder,
a like principal amount of notes (the “Private Exchange Notes”) of the Company, guaranteed by the Guarantors,
that are identical in all material respects to the Exchange Notes except for the placement of a restrictive legend on such Private
Exchange Notes. The Private Exchange Notes shall be issued pursuant to the same indenture as the Exchange Notes and bear the same
CUSIP number as the Exchange Notes if permitted by the CUSIP Service Bureau.

 

In connection with the Exchange Offer, the
Issuers shall:

 

(1)         mail, or cause to be mailed,
to each Holder of record entitled to participate in the Exchange Offer a copy of the Prospectus forming part of the Exchange Offer
Registration Statement, together with an appropriate letter of transmittal and related documents;

 

(2)         use commercially reasonable
efforts to keep the Exchange Offer open for not less than 30 days after the date that notice of the Exchange Offer is mailed to
Holders (or longer if required by applicable law);

 

    	-7-

    	 

    

 

(3)         utilize the services of
a depositary for the Exchange Offer with an address in the Borough of Manhattan, The City of New York;

 

(4)         permit Holders to withdraw
tendered Notes at any time prior to the close of business, New York time, on the last Business Day on which the Exchange Offer
remains open; and

 

(5)         otherwise comply in all
material respects with all applicable laws, rules and regulations.

 

As soon as practicable after the close of
the Exchange Offer and the Private Exchange, if any, the Issuers shall:

 

(1)         accept for exchange all
Registrable Notes validly tendered and not validly withdrawn pursuant to the Exchange Offer and the Private Exchange, if any;

 

(2)         deliver to the Trustee
for cancellation all Registrable Notes so accepted for exchange; and

 

(3)         cause the Trustee to authenticate
and deliver promptly to each Holder of Notes, Exchange Notes or Private Exchange Notes, as the case may be, equal in principal
amount to the Notes of such Holder so accepted for exchange; provided that, in the case of any Notes held in global form
by a depositary, authentication and delivery to such depositary of one or more replacement Notes in global form in an equivalent
principal amount thereto for the account of such Holders in accordance with the Indenture shall satisfy such authentication and
delivery requirement.

 

The Exchange Offer and the Private Exchange
shall not be subject to any conditions, other than that (i) the Exchange Offer or Private Exchange, as the case may be, does
not violate applicable law or any applicable interpretation of the staff of the SEC; (ii) no action or proceeding shall have
been instituted or threatened in any court or by any governmental agency which might materially impair the ability of the Issuers
to proceed with the Exchange Offer or the Private Exchange, and no material adverse development shall have occurred in any existing
action or proceeding with respect to the Issuers; and (iii) all governmental approvals shall have been obtained, which approvals
the Issuers deem necessary for the consummation of the Exchange Offer or Private Exchange.

 

The Exchange Notes and the Private Exchange
Notes shall be issued under (i) the Indenture or (ii) an indenture identical in all material respects to the Indenture
and which, in either case, conforms to the requirements necessary for qualification under the TIA or is exempt from such qualification
and shall provide that the Exchange Notes shall not be subject to the transfer restrictions set forth in the Indenture. The Indenture
or such indenture shall provide that the Exchange Notes, the Private Exchange Notes and the Notes shall vote

 

    	-8-

    	 

    

 

and consent together on all matters as one
class and that none of the Exchange Notes, the Private Exchange Notes or the Notes will have the right to vote or consent as a
separate class on any matter.

 

(c)         If, (i) because of any change
in law or in currently prevailing interpretations of the staff of the SEC, the Issuers are not permitted to effect the Exchange
Offer, (ii) the Exchange Offer is not consummated within 360 days of the Issue Date, (iii) any Holder so requests in
writing to the Company at any time after the consummation of the Exchange Offer with respect to Notes (including Private Exchange
Notes) that were ineligible to be exchanged for Exchange Notes in the Exchange Offer (or in the case of Private Exchange Notes,
were not issued in exchange for Notes that are or were eligible to be exchanged in the Exchange Offer) or (iv)  in the case
of any Holder that participates in the Exchange Offer, such Holder does not receive Exchange Notes on the date of the exchange
that may be sold without restriction under the Securities Act (other than due solely to the status of such Holder as an affiliate
of the Company within the meaning of the Securities Act) and so notifies the Company within 30 days after such Holder first becomes
aware of such restrictions, in the case of each of clauses (i) to and including (iv) of this sentence, then the Issuers shall
promptly deliver to the Holders and the Trustee written notice thereof (the “Shelf Notice”) and shall file
a Shelf Registration pursuant to Section 3 hereof.

 

		3.	Shelf Registration

 

If at any time a Shelf Notice is delivered
as contemplated by Section 2(c) hereof, then:

 

(a)         Shelf Registration.
 The Issuers shall as promptly as practicable file with the SEC a Registration Statement for an offering to be made on a continuous
basis pursuant to Rule 415 covering all of the Registrable Notes (the “Initial Shelf Registration”). The Issuers
shall use commercially reasonable efforts to file with the SEC the Initial Shelf Registration on or prior to the applicable Filing
Date. The Initial Shelf Registration shall be on Form S-1 or another appropriate form permitting registration of such Registrable
Notes for resale by Holders in the manner or manners designated by them (including, without limitation, one or more underwritten
offerings). The Issuers shall not permit any securities other than the Registrable Notes and the Guarantees, and Additional Notes
(if any) and the related guarantees, to be included in the Initial Shelf Registration or any Subsequent Shelf Registration (as
defined below).

 

The Issuers shall use commercially
reasonable efforts to cause the Shelf Registration to be declared effective under the Securities Act on or prior to the Effectiveness
Date and to keep the Initial Shelf Registration continuously effective under the Securities Act until the date that is one year
from the Effectiveness Date or such shorter period ending when all Registrable Notes covered by the Initial Shelf Registration
have been sold in the manner set forth and as contemplated in the Initial Shelf Registration

 

    	-9-

    	 

    

 

or, if applicable, a Subsequent
Shelf Registration (the “Effectiveness Period”); provided, however, that the Effectiveness Period
in respect of the Initial Shelf Registration shall be extended to the extent required to permit dealers to comply with the applicable
prospectus delivery requirements of Rule 174 under the Securities Act and as otherwise provided herein. Notwithstanding anything
to the contrary in this Agreement, at any time, the Company may delay the filing of any Initial Shelf Registration Statement or
delay or suspend the effectiveness thereof, for a reasonable period of time, but not in excess of an aggregate of 75 days in any
calendar year (a “Shelf Suspension Period”), if the Board of Directors of the Company determines reasonably
and in good faith that the filing of any such Initial Shelf Registration Statement or the continuing effectiveness thereof would
require the disclosure of non-public material information that, in the reasonable judgment of the Board of Directors of the Company,
would be detrimental to the Company if so disclosed or would otherwise materially adversely affect a financing, acquisition, disposition,
merger or other material transaction.

 

(b)         Withdrawal of Stop
Orders; Subsequent Shelf Registrations.  If the Initial Shelf Registration or any Subsequent Shelf Registration ceases to be
effective for any reason at any time during the Effectiveness Period (other than because of the sale of all of the Notes registered
thereunder), the Issuers shall use commercially reasonable efforts to obtain the prompt withdrawal of any order suspending the
effectiveness thereof, and in any event shall within 30 days of such cessation of effectiveness amend such Shelf Registration
Statement in a manner to obtain the withdrawal of the order suspending the effectiveness thereof, or file an additional Shelf
Registration Statement pursuant to Rule 415 covering all of the Registrable Notes covered by and not sold under the Initial Shelf
Registration or an earlier Subsequent Shelf Registration (each, a “Subsequent Shelf Registration”). If a Subsequent
Shelf Registration is filed, the Issuers shall use commercially reasonable efforts to cause the Subsequent Shelf Registration
to be declared effective under the Securities Act as soon as practicable after such filing and to keep such subsequent Shelf Registration
continuously effective for a period equal to the number of days in the Effectiveness Period less the aggregate number of days
during which the Initial Shelf Registration or any Subsequent Shelf Registration was previously continuously effective. As used
herein the term “Shelf Registration” means the Initial Shelf Registration and any Subsequent Shelf Registration.

 

(c)         Supplements and Amendments.
 The Issuers shall promptly supplement and amend the Shelf Registration if required by the rules, regulations or instructions applicable
to the registration form used for such Shelf Registration, if required by the Securities Act, or if reasonably requested by the
Holders of a majority in aggregate principal amount of the Registrable Notes (or their counsel) covered by such Registration Statement
with respect to the information included therein with respect to one or

 

    	-10-

    	 

    

 

more of such Holders, or by any
underwriter of such Registrable Notes with respect to the information included therein with respect to such underwriter.

 

		4.	Additional Interest

 

(a)         The Issuers and the Initial Purchasers
agree that the Holders will suffer damages if the Issuers fail to fulfill their obligations under Section 2 or Section 3
hereof and that it would not be feasible to ascertain the extent of such damages with precision. Accordingly, the Issuers agree
to pay, jointly and severally, as liquidated damages, additional interest on the Notes (“Additional Interest”)
under the circumstances and to the extent set forth below (each of which shall be given independent effect):

 

(i)          if (A) neither the Exchange
Offer Registration Statement nor the Initial Shelf Registration has been filed on or prior to the Filing Date applicable thereto
or (B) notwithstanding that the Issuers have consummated or will consummate the Exchange Offer, the Issuers are required to file
a Shelf Registration and such Shelf Registration is not filed on or prior to the Filing Date applicable thereto, then, commencing
on the day after any such Filing Date, Additional Interest shall accrue on the principal amount of the Notes at a rate of 0.25%
per annum for the first 90 days immediately following such applicable Filing Date, and such Additional Interest rate shall increase
by an additional 0.25% per annum at the beginning of each subsequent 90-day period; or

 

(ii)         if (A) neither the Exchange
Offer Registration Statement nor the Initial Shelf Registration is declared effective by the SEC on or prior to the Effectiveness
Date applicable thereto or (B) notwithstanding that the Issuers have consummated or will consummate the Exchange Offer, the
Issuers are required to file a Shelf Registration and such Shelf Registration is not declared effective by the SEC on or prior
to the Effectiveness Date applicable to such Shelf Registration, then, commencing on the day after such Effectiveness Date, Additional
Interest shall accrue on the principal amount of the Notes at a rate of 0.25% per annum for the first 90 days immediately following
the day after such Effectiveness Date, and such Additional Interest rate shall increase by an additional 0.25% per annum at the
beginning of each subsequent 90-day period; or

 

(iii)        if (A) the Issuers
have not exchanged Exchange Notes for all Notes validly tendered in accordance with the terms of the Exchange Offer on or prior
to the 90th day after the date on which the Exchange Offer Registration Statement was declared effective or (B) if applicable,
a Shelf Registration has been declared effective and such Shelf Registration ceases to be effective at any time during the Effectiveness
Period, then Additional Interest shall accrue on the principal amount of the Notes at a rate of 0.25% per annum for the first
90 days commencing on the (x) 91st day after such effective date, in the case of (A) above, or (y) the day such Shelf Registration

 

    	-11-

    	 

    

 

ceases to be effective in the case
of (B) above, and such Additional Interest rate shall increase by an additional 0.25% per annum at the beginning of each such
subsequent 90-day period;

 

provided,
however, that the Additional Interest rate on the Notes may not accrue under more than one of the foregoing clauses (i)
- (iii) at any one time and at no time shall the aggregate amount of Additional Interest accruing exceed in the aggregate 1.0%
per annum; provided, further, however, that (1) upon the filing of the applicable Exchange Offer Registration
Statement or the applicable Shelf Registration as required hereunder (in the case of clause (i) above of this Section 4),
(2) upon the effectiveness of the Exchange Offer Registration Statement or the applicable Shelf Registration Statement as
required hereunder (in the case of clause (ii) of this Section 4), or (3) upon the exchange of the Exchange Notes for
all Notes tendered (in the case of clause (iii)(A) of this Section 4), or upon the effectiveness of the applicable Shelf
Registration Statement which had ceased to remain effective (in the case of (iii)(B) of this Section 4), Additional Interest
on the Notes in respect of which such events relate as a result of such clause (or the relevant subclause thereof), as the case
may be, shall cease to accrue. Notwithstanding any other provision of this Section 4, the Issuers shall not be obligated to pay
Additional Interest provided in Sections 4(a)(i)(B), 4(a)(ii)(B) or 4(a)(iii)(B) during a Shelf Suspension Period permitted by
Section 3(a) hereof.

 

(b)         The Issuers shall notify the Trustee
within one Business Day after each and every date on which an event occurs in respect of which Additional Interest is required
to be paid (an “Event Date”). Any amounts of Additional Interest due pursuant to (a)(i), (a)(ii) or (a)(iii)
of this Section 4 will be payable in cash semiannually on each April 1 and October 1 (to the holders of record on the March
15 and September 15 immediately preceding such dates), commencing with the first such date occurring after any such Additional
Interest commences to accrue. The amount of Additional Interest will be determined by multiplying the applicable Additional Interest
rate by the principal amount of the Registrable Notes, multiplied by a fraction, the numerator of which is the number of days
such Additional Interest rate was applicable during such period (determined on the basis of a 360 day year comprised of twelve
30 day months and, in the case of a partial month, the actual number of days elapsed), and the denominator of which is 360.

 

		5.	Registration Procedures

 

In connection with the filing of any Registration
Statement pursuant to Section 2 or 3 hereof, the Issuers shall effect such registrations to permit the sale of the securities
covered thereby in accordance with the intended method or methods of disposition thereof, and pursuant thereto and in connection
with any Registration Statement filed by the Company hereunder, each of the Issuers shall:

 

(a)         Prepare and file with
the SEC prior to the applicable Filing Date a Registration Statement or Registration Statements as prescribed by Section 2
or 3 hereof,

 

    	-12-

    	 

    

 

and use commercially reasonable
efforts to cause each such Registration Statement to become effective and remain effective as provided herein; provided,
however, that if (1) such filing is pursuant to Section 3 hereof or (2) a Prospectus contained in the Exchange
Offer Registration Statement filed pursuant to Section 2 hereof is required to be delivered under the Securities Act by any
Participating Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period relating thereto from whom the Company
has received prior written notice that it will be a Participating Broker-Dealer in the Exchange Offer, before filing any Registration
Statement or Prospectus or any amendments or supplements thereto, the Issuers shall furnish to and afford the Holders of the Registrable
Notes covered by such Registration Statement (with respect to a Registration Statement filed pursuant to Section 3 hereof)
or each such Participating Broker-Dealer (with respect to any such Registration Statement), as the case may be, their counsel
and the managing underwriters, if any, a reasonable opportunity to review copies of all such documents (including copies of any
documents to be incorporated by reference therein and all exhibits thereto) proposed to be filed (in each case at least five Business
Days prior to such filing). The Issuers shall not file any Registration Statement or Prospectus or any amendments or supplements
thereto if the Holders of a majority in aggregate principal amount of the Registrable Notes covered by such Registration Statement,
their counsel, or the managing underwriters, if any, shall reasonably object on a timely basis.

 

(b)         Use commercially reasonable
efforts to prepare and file with the SEC such amendments and post-effective amendments to each Shelf Registration Statement or
Exchange Offer Registration Statement, as the case may be, as may be necessary to keep such Registration Statement continuously
effective for the Effectiveness Period, the Applicable Period or until consummation of the Exchange Offer, as the case may be;
cause the related Prospectus to be supplemented by any Prospectus supplement required by applicable law, and as so supplemented
to be filed pursuant to Rule 424; and comply with the provisions of the Securities Act and the Exchange Act applicable to
it with respect to the disposition of all securities covered by such Registration Statement as so amended or in such Prospectus
as so supplemented and with respect to the subsequent resale of any securities being sold by an Participating Broker-Dealer covered
by any such Prospectus. The Company shall be deemed not to have used commercially reasonable efforts to keep a Registration Statement
effective if such Issuer voluntarily takes any action that would result in selling Holders of the Registrable Notes covered thereby
or Participating Broker-Dealers seeking to sell Exchange Notes not being able to sell such Registrable Notes or such Exchange
Notes during that period unless such action is required by applicable law or permitted by this Agreement.

 

(c)         If (1) a Shelf Registration
is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration Statement filed
pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating

 

    	-13-

    	 

    

 

Broker-Dealer who seeks to sell
Exchange Notes during the Applicable Period relating thereto from whom the Company has received written notice that it will be
a Participating Broker-Dealer in the Exchange Offer, notify the selling Holders of Registrable Notes (with respect to a Registration
Statement filed pursuant to Section 3 hereof), or each such Participating Broker-Dealer (with respect to any such Registration
Statement), as the case may be, their counsel and the managing underwriters, if any, promptly (but in any event within one Business
Day), and confirm such notice in writing, (i) when a Prospectus or any Prospectus supplement or post-effective amendment
has been filed, and, with respect to a Registration Statement or any post-effective amendment, when the same has become effective
under the Securities Act (including in such notice a written statement that any Holder may, upon request, obtain, at the sole
expense of the Company, one conformed copy of such Registration Statement or post-effective amendment including financial statements
and schedules, documents incorporated or deemed to be incorporated by reference and exhibits), (ii) of the issuance by the
SEC of any stop order suspending the effectiveness of a Registration Statement or of any order preventing or suspending the use
of any preliminary prospectus or the initiation of any proceedings for that purpose, (iii) if at any time when a prospectus
is required by the Securities Act to be delivered in connection with sales of the Registrable Notes or resales of Exchange Notes
by Participating Broker-Dealers the representations and warranties of the Issuers contained in any agreement (including any underwriting
agreement) contemplated by Section 5(n) hereof cease to be true and correct, (iv) of the receipt by any Issuer of any
notification with respect to the suspension of the qualification or exemption from qualification of a Registration Statement or
any of the Registrable Notes or the Exchange Notes to be sold by any Participating Broker-Dealer for offer or sale in any jurisdiction,
or the initiation or threatening of any proceeding for such purpose, (v) of the happening of any event, the existence of
any condition or any information becoming known that makes any statement made in such Registration Statement or related Prospectus
or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or that requires
the making of any changes in or amendments or supplements to such Registration Statement, Prospectus or documents so that, in
the case of the Registration Statement, it will not contain any untrue statement of a material fact or omit to state any material
fact required to be stated therein or necessary to make the statements therein not misleading, and that in the case of the Prospectus,
it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or
necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading, and (vi) of
the Issuers’ determination that a post-effective amendment to a Registration Statement would be appropriate.

 

(d)         Use commercially reasonable
efforts to prevent the issuance of any order suspending the effectiveness of a Registration Statement or of any order preventing

 

    	-14-

    	 

    

 

or suspending the use of a Prospectus
or suspending the qualification (or exemption from qualification) of any of the Registrable Notes or the Exchange Notes to be
sold by any Participating Broker-Dealer, for sale in any jurisdiction, and, if any such order is issued, to use commercially reasonable
efforts to obtain the withdrawal of any such order at the earliest practicable date.

 

(e)         If a Shelf Registration
is filed pursuant to Section 3 and if requested in writing during the Effectiveness Period by the managing underwriter or
underwriters (if any), the Holders of a majority in aggregate principal amount of the Registrable Notes being sold in connection
with an underwritten offering or any Participating Broker-Dealer, (i) as promptly as practicable incorporate in a prospectus
supplement or post-effective amendment such information as the managing underwriter or underwriters (if any), such Holders, any
Participating Broker-Dealer or counsel for any of them reasonably request to be included therein, (ii) make all required
filings of such prospectus supplement or such post-effective amendment as soon as practicable after the Company has received notification
of the matters to be incorporated in such prospectus supplement or post-effective amendment, and (iii) supplement or make
amendments to such Registration Statement; provided, however, the Issuers shall not be required to take any action pursuant to
this Section 5(e) that would, in the opinion of counsel for the Company, reasonably satisfactory to the Initial Purchasers, violate
applicable law.

 

(f)          If (1) a Shelf Registration
is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration Statement filed
pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Notes during the Applicable Period, furnish to each selling Holder of Registrable Notes (with respect to
a Registration Statement filed pursuant to Section 3 hereof) and to each such Participating Broker-Dealer who so requests
(with respect to any such Registration Statement) and to their respective counsel and each managing underwriter, if any, at the
sole expense of the Company, one conformed copy of the Registration Statement or Registration Statements and each post-effective
amendment thereto, including financial statements and schedules, and, if requested, all documents incorporated or deemed to be
incorporated therein by reference and all exhibits.

 

(g)         If (1) a Shelf Registration
is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration Statement filed
pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Notes during the Applicable Period, deliver to each selling Holder of Registrable Notes (with respect to
a Registration Statement filed pursuant to Section 3 hereof), or each such Participating Broker-Dealer (with respect to any
such Registration Statement), as the case may be, their respective

 

    	-15-

    	 

    

 

counsel, and the underwriters,
if any, at the sole expense of the Company, as many copies of the Prospectus or Prospectuses (including each form of preliminary
prospectus) and each amendment or supplement thereto and any documents incorporated by reference therein as such Persons may reasonably
request; and, subject to the last paragraph of this Section 5, the Issuers hereby consent to the use of such Prospectus and
each amendment or supplement thereto by each of the selling Holders of Registrable Notes or each such Participating Broker-Dealer,
as the case may be, and the underwriters or agents, if any, and dealers, if any, in connection with the offering and sale of the
Registrable Notes covered by, or the sale by Participating Broker-Dealers of the Exchange Notes pursuant to, such Prospectus and
any amendment or supplement thereto.

 

(h)         Prior to any public offering
of Registrable Notes or any delivery of a Prospectus contained in the Exchange Offer Registration Statement by any Participating
Broker-Dealer who seeks to sell Exchange Notes during the Applicable Period, use commercially reasonable efforts to register or
qualify, and to cooperate with the selling Holders of Registrable Notes or each such Participating Broker-Dealer, as the case
may be, the managing underwriter or underwriters, if any, and their respective counsel in connection with the registration or
qualification (or exemption from such registration or qualification) of such Registrable Notes for offer and sale under the securities
or Blue Sky laws of such jurisdictions within the United States as any selling Holder, Participating Broker-Dealer, or the managing
underwriter or underwriters reasonably request in writing; provided, however, that where Exchange Notes held by
Participating Broker-Dealers or Registrable Notes are offered other than through an underwritten offering, the Issuers agree to
cause their counsel to perform Blue Sky investigations and file registrations and qualifications required to be filed pursuant
to this Section 5(h), keep each such registration or qualification (or exemption therefrom) effective during the period such
Registration Statement is required to be kept effective and do any and all other acts or things necessary or advisable to enable
the disposition in such jurisdictions of the Exchange Notes held by Participating Broker-Dealers or the Registrable Notes covered
by the applicable Registration Statement; provided, however, that no Issuer shall be required to (A) qualify
generally to do business in any jurisdiction where it is not then so qualified, (B) take any action that would subject it
to general service of process in any such jurisdiction where it is not then so subject or (C) subject itself to taxation
in excess of a nominal dollar amount in any such jurisdiction where it is not then so subject.

 

(i)          If a Shelf Registration
is filed pursuant to Section 3 hereof, cooperate with the selling Holders of Registrable Notes and the managing underwriter
or underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Registrable Notes to be
sold, which certificates shall not bear any restrictive legends and shall be in a form eligible for deposit with The Depository
Trust Company;

 

    	-16-

    	 

    

 

and enable such Registrable Notes
to be in such denominations (subject to applicable requirements contained in the Indenture) and registered in such names as the
managing underwriter or underwriters, if any, or Holders may request.

 

(j)          Use commercially reasonable
efforts to cause the Registrable Notes covered by the Registration Statement to be registered with or approved by such other governmental
agencies or authorities as may be necessary to enable the seller or sellers thereof or the underwriter or underwriters, if any,
to consummate the disposition of such Registrable Notes, except as may be required solely as a consequence of the nature of such
selling Holder’s business, in which case the Issuers will cooperate in all respects with the filing of such Registration
Statement and the granting of such approvals; provided that no Issuer shall be required
to (A) qualify generally to do business in any jurisdiction where it is not then so qualified, (B) take any action that would
subject it to general service of process in any jurisdiction where it is not then so subject or (C) subject itself to taxation
in excess of a nominal dollar amount in any such jurisdiction it is not then so subject.

 

(k)         If (1) a Shelf Registration
is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration Statement filed
pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Notes during the Applicable Period, upon the occurrence of any event contemplated by paragraph 5(c)(v)
or 5(c)(vi) hereof, as promptly as practicable prepare and (subject to Section 5(a) hereof) file with the SEC, at the sole
expense of the Company, a supplement or post-effective amendment to the Registration Statement or a supplement to the related
Prospectus or any document incorporated or deemed to be incorporated therein by reference, or file any other required document
so that, as thereafter delivered to the purchasers of the Registrable Notes being sold thereunder (with respect to a Registration
Statement filed pursuant to Section 3 hereof) or to the purchasers of the Exchange Notes to whom such Prospectus will be
delivered by a Participating Broker-Dealer (with respect to any such Registration Statement), any such Prospectus will not contain
an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein, in the light of the circumstances under which they were made, not misleading.

 

(l)          Use commercially reasonable
efforts to cause the Registrable Notes covered by a Registration Statement or the Exchange Notes, as the case may be, to be rated
with the appropriate rating agencies, if so requested by the Holders of a majority in aggregate principal amount of Registrable
Notes covered by such Registration Statement or the Exchange Notes, as the case may be, or the managing underwriter or underwriters,
if any.

 

    	-17-

    	 

    

 

(m)        Prior to the effective
date of the first Registration Statement relating to the Registrable Notes, (i) provide the Trustee with certificates for
the Registrable Notes in a form eligible for deposit with The Depository Trust Company and (ii) provide a CUSIP number for
the Registrable Notes.

 

(n)         In connection with any
underwritten offering of Registrable Notes pursuant to a Shelf Registration, enter into an underwriting agreement as is customary
in underwritten offerings of debt securities similar to the Notes, and take all such other actions as are reasonably requested
by the managing underwriter or underwriters in order to expedite or facilitate the registration or the disposition of such Registrable
Notes and, in such connection, (i) make such representations and warranties to, and covenants with, the underwriters with
respect to the business of the Issuers (including any acquired business, properties or entity, if applicable), and the Registration
Statement, Prospectus and documents, if any, incorporated or deemed to be incorporated by reference therein, in each case, as
are customarily made by issuers to underwriters in underwritten offerings of debt securities similar to the Notes, and confirm
the same in writing if and when requested; (ii) obtain the written opinions of counsel to the Issuers, and written updates
thereof in form, scope and substance reasonably satisfactory to the managing underwriter or underwriters, addressed to the underwriters
covering the matters customarily covered in opinions reasonably requested in underwritten offerings of debt securities similar
to the Notes; (iii) obtain “cold comfort” letters and updates thereof in form, scope and substance reasonably
satisfactory to the managing underwriter or underwriters from the independent certified public accountants of the Issuers (and,
if necessary, any other independent certified public accountants of the Issuers, or of any business acquired by the Issuers, for
which financial statements and financial data are, or are required to be, included or incorporated by reference in the Registration
Statement), addressed to each of the underwriters, such letters to be in customary form and covering matters of the type customarily
covered in “cold comfort” letters in connection with underwritten offerings of debt securities similar to the Notes;
and (iv) if an underwriting agreement is entered into, the same shall contain indemnification provisions and procedures no
less favorable to the sellers and underwriters, if any, than those set forth in Section 7 hereof (or such other provisions
and procedures reasonably acceptable to Holders of a majority in aggregate principal amount of Registrable Notes covered by such
Registration Statement and the managing underwriter or underwriters or agents, if any). The above shall be done at each closing
under such underwriting agreement, or as and to the extent required thereunder. Notwithstanding
the foregoing, the Issuers may delay entering into such agreement in the event that and for a period of time not to exceed an
aggregate of 60 days if (1) the Board of Directors of the Company determines in good faith that the disclosure of an event at
such time could reasonably be expected to have a material adverse effect on the business, operations or prospects of the Issuers
or (2) the disclosure otherwise relates to a material business transaction which has not been publicly disclosed and the 

 

    	-18-

    	 

    

 

Board
of Directors of the Company determines that any such disclosure would jeopardize the success of such transaction.

 

(o)         If (1) a Shelf Registration
is filed pursuant to Section 3 hereof, or (2) a Prospectus contained in the Exchange Offer Registration Statement filed
pursuant to Section 2 hereof is required to be delivered under the Securities Act by any Participating Broker-Dealer who
seeks to sell Exchange Notes during the Applicable Period, make available for inspection by any Initial Purchaser, any selling
Holder of such Registrable Notes being sold (with respect to a Registration Statement filed pursuant to Section 3 hereof),
or each such Participating Broker-Dealer, as the case may be, any underwriter participating in any such disposition of Registrable
Notes, if any, and any attorney, accountant or other agent retained by any such selling Holder or each such Participating Broker-Dealer
(with respect to any such Registration Statement), as the case may be, or underwriter (any such Initial Purchasers, Holders, Participating
Broker-Dealers, underwriters, attorneys, accountants or agents, collectively, the “Inspectors”), upon written
request, at the offices where normally kept, during reasonable business hours, all pertinent financial and other records, pertinent
corporate documents and instruments of the Company and subsidiaries of the Company (collectively, the “Records”),
as shall be reasonably necessary to enable them to exercise any applicable due diligence responsibilities, and cause the officers,
directors and employees of the Company and any of its subsidiaries to supply all information (“Information”)
reasonably requested by any such Inspector in connection with such due diligence responsibilities. Each Inspector shall agree
in writing that it will keep the Records and Information confidential and that it will not disclose any of the Records or Information
that the Company determines, in good faith, to be confidential and notifies the Inspectors in writing are confidential, and that
such information will be treated as confidential by it so as not to give rise to disclosure obligations on the part of the Issuer
under SEC Regulation FD unless (i) the disclosure of such Records or Information is necessary to avoid or correct a misstatement
or omission in such Registration Statement or Prospectus, (ii) the release of such Records or Information is ordered pursuant
to a subpoena or other order from a court of competent jurisdiction, (iii) disclosure of such Records or Information is necessary
or advisable, in the opinion of counsel for any Inspector, in connection with any action, claim, suit or proceeding, directly
or indirectly, involving or potentially involving such Inspector and arising out of, based upon, relating to, or involving this
Agreement or the Purchase Agreement, or any transactions contemplated hereby or thereby or arising hereunder or thereunder, or
(iv) the information in such Records or Information has been made generally available to the public other than by an Inspector
or an “affiliate” (as defined in Rule 405) thereof; provided, however, that prior notice shall
be provided as soon as practicable to the Company of the potential disclosure of any information by such Inspector pursuant to
clauses (i) or (ii) of this sentence to permit the Company to obtain a protective order (or waive the provisions of
this paragraph (o)) and that such Inspector shall take such actions as are

 

    	-19-

    	 

    

 

reasonably necessary to protect
the confidentiality of such information (if practicable) to the extent such action is otherwise not inconsistent with, an impairment
of or in derogation of the rights and interests of the Holder or any Inspector.

 

(p)         Provide an indenture trustee
for the Registrable Notes or the Exchange Notes, as the case may be, and, unless exempt from qualification, cause the Indenture
or the trust indenture provided for in Section 2(a) hereof, as the case may be, to be qualified under the TIA not later than
the effective date of the first Registration Statement relating to the Registrable Notes; and in connection therewith, cooperate
with the trustee under any such indenture and the Holders of the Registrable Notes to effect such changes (if any) to such indenture
as may be required for such indenture to be so qualified in accordance with the terms of the TIA; and execute, and use commercially
reasonable efforts to cause such trustee to execute, all documents as may be required to effect such changes, and all other forms
and documents required to be filed with the SEC to enable such indenture to be so qualified in a timely manner.

 

(q)         Comply with all applicable
rules and regulations of the SEC and make generally available to its securityholders with regard to any applicable Registration
Statement, a consolidated earnings statement satisfying the provisions of Section 11(a) of the Securities Act and Rule 158
thereunder (or any similar rule promulgated under the Securities Act) no later than 45 days after the end of any fiscal quarter
(or 90 days after the end of any 12-month period if such period is a fiscal year) (i) commencing at the end of any fiscal
quarter in which Registrable Notes are sold to underwriters in a firm commitment or best efforts underwritten offering and (ii) if
not sold to underwriters in such an offering, commencing on the first day of the first fiscal quarter of the Company, after the
effective date of a Registration Statement, which statements shall cover said 12-month periods.

 

(r)          If the Exchange Offer
or a Private Exchange is to be consummated, upon delivery of the Registrable Notes by Holders to the Company (or to such other
Person as directed by the Company), in exchange for the Exchange Notes or the Private Exchange Notes, as the case may be, the
Issuers shall mark, or cause to be marked, on such Registrable Notes that such Registrable Notes are being cancelled in exchange
for the Exchange Notes or the Private Exchange Notes, as the case may be; in no event shall such Registrable Notes be marked as
paid or otherwise satisfied.

 

(s)         Cooperate with each seller
of Registrable Notes covered by any Registration Statement and each underwriter, if any, participating in the disposition of such
Registrable Notes and their respective counsel in connection with any filings required to be made with FINRA.

 

    	-20-

    	 

    

 

(t)          Use commercially reasonable
efforts to take all other steps necessary to effect the registration of the Exchange Notes and/or Registrable Notes covered by
a Registration Statement contemplated hereby.

 

The Company may require each seller of Registrable
Notes as to which any registration is being effected to furnish to the Company such information regarding such seller and the
distribution of such Registrable Notes as the Company may, from time to time, reasonably request. The Company may exclude from
such registration the Registrable Notes of any seller so long as such seller fails to furnish such information within a reasonable
time after receiving such request. Each seller as to which any Shelf Registration is being effected agrees to furnish promptly
to the Company all information required to be disclosed in order to make the information previously furnished to the Company by
such seller not materially misleading.

 

If any such Registration Statement refers
to any Holder by name or otherwise as the holder of any securities of any Issuer, then such Holder shall have the right to require
(i) the insertion therein of language, in form and substance reasonably satisfactory to such Holder, to the effect that the
holding by such Holder of such securities is not to be construed as a recommendation by such Holder of the investment quality
of the securities covered thereby and that such holding does not imply that such Holder will assist in meeting any future financial
requirements of the Issuers, or (ii) in the event that such reference to such Holder by name or otherwise is not required
by the Securities Act or any similar federal statute then in force, the deletion of the reference to such Holder in any amendment
or supplement to the Registration Statement filed or prepared subsequent to the time that such reference ceases to be required.

 

Each Holder of Registrable Notes and each
Participating Broker-Dealer agrees by its acquisition of such Registrable Notes or Exchange Notes to be sold by such Participating
Broker-Dealer, as the case may be, that, upon actual receipt of any notice from the Company of the happening of any event of the
kind described in Section 5(c)(ii), 5(c)(iv), 5(c)(v), or 5(c)(vi) hereof, such Holder will forthwith discontinue disposition
of such Registrable Notes covered by such Registration Statement or Prospectus or Exchange Notes to be sold by such Holder or
Participating Broker-Dealer, as the case may be, and in each case, dissemination of such Prospectus, until such Holder’s
or Participating Broker-Dealer’s receipt of the copies of the supplemented or amended Prospectus contemplated by Section 5(k)
hereof, or until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus
may be resumed, and has received copies of any amendments or supplements thereto. In the event that the Issuers shall give any
such notice, each of the Applicable Period and the Effectiveness Period shall be extended by the number of days during such periods
from and including the date of the giving of such notice to and including the date when each seller of Registrable Notes covered
by such Registration Statement or Exchange Notes to be sold by

 

    	-21-

    	 

    

 

such Participating Broker-Dealer, as the
case may be, shall have received (x) the copies of the supplemented or amended Prospectus contemplated by Section 5(k)
hereof or (y) the Advice.

 

		6.	Registration Expenses

 

All fees and expenses incident to the performance
of or compliance with this Agreement by the Issuers shall be borne by the Company, whether or not the Exchange Offer Registration
Statement or any Shelf Registration Statement is filed or becomes effective or the Exchange Offer is consummated, including, without
limitation, (i) all registration and filing fees (including, without limitation, (A) fees with respect to filings required
to be made with FINRA in connection with an underwritten offering and (B) fees and expenses of compliance with state securities
or Blue Sky laws where required (including, without limitation, fees and disbursements of counsel in connection with Blue Sky
qualifications of the Registrable Notes or Exchange Notes and determination of the eligibility of the Registrable Notes or Exchange
Notes for investment under the laws of such jurisdictions (x) where the holders of Registrable Notes are located, in the
case of the Exchange Notes, or (y) as provided in Section 5(h) hereof, in the case of Registrable Notes or Exchange
Notes to be sold by a Participating Broker-Dealer during the Applicable Period)), (ii) printing expenses, including, without
limitation, expenses of printing certificates for Registrable Notes or Exchange Notes in a form eligible for deposit with The
Depository Trust Company and of printing prospectuses if the printing of prospectuses is requested by the managing underwriter
or underwriters, if any, by the Holders of a majority in aggregate principal amount of the Registrable Notes included in any Registration
Statement or in respect of Registrable Notes or Exchange Notes to be sold by any Participating Broker-Dealer during the Applicable
Period, as the case may be, (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of counsel
for the Issuers and, in the case of a Shelf Registration, reasonable fees and disbursements of one special counsel for all of
the sellers of Registrable Notes selected by the Holders of a majority in aggregate principal amount of Registrable Notes covered
by such Shelf Registration (exclusive of any counsel retained pursuant to Section 7 hereof), (v) fees and disbursements of
all independent certified public accountants referred to in Section 5(n)(iii) hereof (including, without limitation, the expenses
of any “cold comfort” letters required by or incident to such performance), (vi) Securities Act liability insurance,
if the Issuers desire such insurance, (vii) fees and expenses of all other Persons retained by the Issuers, (viii) internal
expenses of the Issuers (including, without limitation, all salaries and expenses of officers and employees of the Issuers performing
legal or accounting duties), (ix) the expense of any annual audit, (x) any fees and expenses incurred in connection
with the listing of the securities to be registered on any securities exchange, and the obtaining of a rating of the securities,
in each case, if applicable and (xi) the expenses relating to printing, word processing and distributing all Registration
Statements, underwriting agreements, indentures and any other documents necessary in order to comply with this Agreement. Notwithstanding
the foregoing, the Issuers shall not pay underwriting or brokerage discounts or commissions.

 

    	-22-

    	 

    

 

		7.	Indemnification
and Contribution.

 

(a)         Each of the Issuers agree, jointly
and severally, to indemnify and hold harmless each Holder of Registrable Notes and each Participating Broker-Dealer selling Exchange
Notes during the Applicable Period, and each Person, if any, who controls such Person or its affiliates within the meaning of
Section 15 of the Act or Section 20 of the Exchange Act (each, a “Participant”) against any losses, claims,
damages or liabilities to which any Participant may become subject under the Securities Act, the Exchange Act or otherwise, insofar
as any such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon:

 

(i)          any untrue statement or
alleged untrue statement made by any Issuer contained in any application or any other document or any amendment or supplement
thereto executed by any Issuer based upon written information furnished by or on behalf of any Issuer filed in any jurisdiction
in order to qualify the Notes under the securities or “Blue Sky” laws thereof or filed with the SEC or any securities
association or securities exchange (each, an “Application”);

 

(ii)         any untrue statement
or alleged untrue statement of any material fact contained in any Registration Statement (or any amendment thereto) or Prospectus
(as amended or supplemented if any of the Issuers shall have furnished any amendments or supplements thereto) or any preliminary
prospectus; or

 

(iii)        the omission or alleged
omission to state, in any Registration Statement (or any amendment thereto) or Prospectus (as amended or supplemented if any of
the Issuers shall have furnished any amendments or supplements thereto) or any preliminary prospectus or any Application or any
other document or any amendment or supplement thereto, a material fact required to be stated therein or necessary to make the
statements therein not misleading;

 

and will reimburse, as incurred, the Participant for any legal
or other expenses incurred by the Participant in connection with investigating, defending against or appearing as a third-party
witness in connection with any such loss, claim, damage, liability or action; provided, however, none of the Issuers
will be liable in any such case to the extent that any such loss, claim, damage, or liability arises out of or is based upon any
untrue statement or alleged untrue statement or omission or alleged omission made in any Registration Statement (or any amendment
thereto) or Prospectus (as amended or supplemented if any of the Issuers shall have furnished any amendments or supplements thereto)
or any preliminary prospectus or Application or any amendment or supplement thereto in reliance upon and in conformity with information
relating to any Participant furnished to the Issuers by such Participant specifically for use therein. The indemnity provided
for in this Section 7 will be in addition to any liability that the Issuers may otherwise have to the indemnified parties.
The Issuers shall not be

 

    	-23-

    	 

    

 

liable under this Section 7 for any settlement of any
claim or action effected without their prior written consent, which shall not be unreasonably withheld.

 

(b)         Each Participant, severally and not
jointly, agrees to indemnify and hold harmless the Issuers, their directors, their officers and each Person, if any, who controls
the Issuers within the meaning of Section 15 of the Act or Section 20 of the Exchange Act against any losses, claims, damages
or liabilities to which the Issuers or any such director, officer or controlling person may become subject under the Act, the
Exchange Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of
or are based upon (i) any untrue statement or alleged untrue statement of any material fact contained in any Registration
Statement, Prospectus or Application, any amendment or supplement thereto, or any preliminary prospectus, or (ii) the omission
or the alleged omission to state therein a material fact necessary to make the statements therein not misleading, in each case
to the extent, but only to the extent, that such untrue statement or alleged untrue statement or omission or alleged omission
was made in reliance upon and in conformity with written information concerning such Participant, furnished to the Issuers by
the Participant, specifically for use therein; and subject to the limitation set forth immediately preceding this clause, will
reimburse, as incurred, any reasonable legal or other expenses incurred by the Issuers or any such director, officer or controlling
person in connection with investigating or defending against or appearing as a third party witness in connection with any such
loss, claim, damage, liability or action in respect thereof. The indemnity provided for in this Section 7 will be in addition
to any liability that the Participants may otherwise have to the indemnified parties. The Participants shall not be liable under
this Section 7 for any settlement of any claim or action effected without their consent, which shall not be unreasonably
withheld. The Issuers shall not, without the prior written consent of such Participant, effect any settlement or compromise of
any pending or threatened proceeding in respect of which such Participant is or could have been a party, or indemnity could have
been sought hereunder by such Participant, unless such settlement (A) includes an unconditional written release of such Participant,
in form and substance reasonably satisfactory to such Participant, from all liability on claims that are the subject matter of
such proceeding and (B) does not include any statement as to an admission of fault, culpability or failure to act by or on behalf
of such Participant.

 

(c)         Promptly after receipt by an indemnified
party under this Section 7 of notice of the commencement of any action for which such indemnified party is entitled to indemnification
under this Section 7, such indemnified party will, if a claim in respect thereof is to be made against the indemnifying party
under this Section 7, notify the indemnifying party of the commencement thereof in writing; but the omission to so notify the
indemnifying party (i) will not relieve it from any liability under paragraph (a) or (b) above unless and to the extent such
failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii) will not, in any
event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation
provided in paragraphs (a)

 

    	-24-

    	 

    

 

and (b) above. In case any such action is
brought against any indemnified party, and it notifies the indemnifying party of the commencement thereof, the indemnifying party
will be entitled to participate therein and, to the extent that it may wish, jointly with any other indemnifying party similarly
notified, to assume the defense thereof, with counsel reasonably satisfactory to such indemnified party; provided, however,
that if (i) the use of counsel chosen by the indemnifying party to represent the indemnified party would present such counsel
with a conflict of interest, (ii) the defendants in any such action include both the indemnified party and the indemnifying
party and the indemnified party shall have been advised by counsel that there may be one or more legal defenses available to it
and/or other indemnified parties that are different from or additional to those available to the indemnifying party, or (iii) the
indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after receipt by the indemnifying party of notice of the institution of such action, then, in each
such case, the indemnifying party shall not have the right to direct the defense of such action on behalf of such indemnified
party or parties and such indemnified party or parties shall have the right to select separate counsel to defend such action on
behalf of such indemnified party or parties. After notice from the indemnifying party to such indemnified party of its election
so to assume the defense thereof and approval by such indemnified party of counsel appointed to defend such action, the indemnifying
party will not be liable to such indemnified party under this Section 7 for any legal or other expenses, other than reasonable
costs of investigation, subsequently incurred by such indemnified party in connection with the defense thereof, unless (i) the
indemnified party shall have employed separate counsel in accordance with the proviso to the immediately preceding sentence (it
being understood, however, that in connection with such action the indemnifying party shall not be liable for the expenses of
more than one separate counsel (in addition to local counsel) in any one action or separate but substantially similar actions
in the same jurisdiction arising out of the same general allegations or circumstances, designated by Participants who sold a majority
in interest of the Registrable Notes and Exchange Notes sold by all such Participants in the case of paragraph (a) of this Section
7 or the Issuers in the case of paragraph (b) of this Section 7, representing the indemnified parties under such paragraph (a)
or paragraph (b), as the case may be, who are parties to such action or actions) or (ii) the indemnifying party has authorized
in writing the employment of counsel for the indemnified party at the expense of the indemnifying party. All fees and expenses
reimbursed pursuant to this paragraph (c) shall be reimbursed as they are incurred. After such notice from the indemnifying party
to such indemnified party, the indemnifying party will not be liable for the costs and expenses of any settlement of such action
effected by such indemnified party without the prior written consent of the indemnifying party (which consent shall not be unreasonably
withheld), unless such indemnified party waived in writing its rights under this Section 7, in which case the indemnified
party may effect such a settlement without such consent.

 

(d)         In circumstances in which the indemnity
agreement provided for in the preceding paragraphs of this Section 7 is unavailable to, or insufficient to hold harmless,
an

 

    	-25-

    	 

    

 

indemnified party in respect of any losses,
claims, damages or liabilities (or actions in respect thereof), each indemnifying party, in order to provide for just and equitable
contribution, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, claims, damages
or liabilities (or actions in respect thereof) in such proportion as is appropriate to reflect (i) the relative benefits received
by the indemnifying party or parties on the one hand and the indemnified party on the other from the offering of the Notes or
(ii) if the allocation provided by the foregoing clause (i) is not permitted by applicable law, not only such relative benefits
but also the relative fault of the indemnifying party or parties on the one hand and the indemnified party on the other in connection
with the statements or omissions or alleged statements or omissions that resulted in such losses, claims, damages or liabilities
(or actions in respect thereof). The relative benefits received by the Company on the one hand and such Participant on the other
shall be deemed to be in the same proportion as the total proceeds from the offering (before deducting expenses) of the Notes
received by the Company bear to the total net profit received by such Participant in connection with the sale of the Notes. The
relative fault of the parties shall be determined by reference to, among other things, whether the untrue or alleged untrue statement
of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the Issuers
on the one hand, or the Participants on the other, the parties’ relative intent, knowledge, access to information and opportunity
to correct or prevent such statement or omission or alleged statement or omission, and any other equitable considerations appropriate
in the circumstances. The parties agree that it would not be equitable if the amount of such contribution were determined by pro
rata or per capita allocation or by any other method of allocation that does not take into account the equitable considerations
referred to in the first sentence of this paragraph (d). Notwithstanding any other provision of this paragraph (d), no Participant
shall be obligated to make contributions hereunder that in the aggregate exceed the total net profit received by such Participant
in connection with the sale of the Notes, less the aggregate amount of any damages that such Participant has otherwise been required
to pay by reason of the untrue or alleged untrue statements or the omissions or alleged omissions to state a material fact, and
no person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled
to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this paragraph (d), each
person, if any, who controls a Participant within the meaning of Section 15 of the Act or Section 20 of the Exchange
Act shall have the same rights to contribution as the Participants, and each director of the Issuers, each officer of the Issuers
and each person, if any, who controls the Issuers within the meaning of Section 15 of the Act or Section 20 of the Exchange
Act, shall have the same rights to contribution as the Issuers.

 

		8.	Rules 144 and 144A

 

The Issuers covenant and agree that they
will file the reports required to be filed by them under the Securities Act and the Exchange Act and the rules and regulations
adopted by the SEC thereunder in a timely manner in accordance with the requirements of the

 

    	-26-

    	 

    

 

Securities Act and the Exchange Act and,
if at any time the Company or any Guarantor is not required to file such reports, the Company or such Guarantor, as the case may
be, will, upon the request of any Holder or beneficial owner of Registrable Notes, make available such information necessary to
permit sales pursuant to Rule 144A. The Issuers further covenant and agree, for so long as any Registrable Notes remain outstanding,
that they will take such further action as any Holder of Registrable Notes may reasonably request, all to the extent required
from time to time to enable such holder to sell Registrable Notes without registration under the Securities Act within the limitation
of the exemptions provided by Rule 144 and Rule 144A.

 

		9.	Underwritten Registrations

 

If any of the Registrable Notes covered by
any Shelf Registration are to be sold in an underwritten offering, the investment banker or investment bankers and manager or
managers that will manage the offering will be selected by the Holders of a majority in aggregate principal amount of such Registrable
Notes included in such offering and shall be reasonably acceptable to the Company.

 

No Holder of Registrable Notes may participate
in any underwritten registration hereunder unless such Holder (a) agrees to sell such Holder’s Registrable Notes on
the basis provided in any underwriting arrangements approved by the Persons entitled hereunder to approve such arrangements and
(b) completes and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents
required under the terms of such underwriting arrangements.

 

		10.	Miscellaneous

 

(a)         No Inconsistent Agreements.
 None of the Issuers has entered, as of the date hereof, and none of the Issuers shall enter, after the date of this Agreement,
into any agreement with respect to any of its securities that is inconsistent with the rights granted to the Holders of Registrable
Notes in this Agreement or otherwise conflicts with the provisions hereof. The rights granted to the Holders hereunder do not
in any way conflict with and are not inconsistent with the rights granted to the holders of the Issuers’ other issued and
outstanding securities under any such agreements.

 

(b)         Adjustments Affecting Registrable
Notes.  The Issuers shall not, directly or indirectly, take any action with respect to the Registrable Notes as a class that
would adversely affect the ability of the Holders of Registrable Notes to include such Registrable Notes in a registration undertaken
pursuant to this Agreement.

 

(c)         Amendments and Waivers.  The
provisions of this Agreement may not be amended, modified or supplemented, and waivers or consents to departures from the provisions
hereof may not be given, otherwise than with the prior written consent of (I) the Issuers,

 

    	-27-

    	 

    

 

and (II) (A) the Holders of not
less than a majority in aggregate principal amount of the then outstanding Registrable Notes and (B) in circumstances that
would adversely affect the Participating Broker-Dealers, the Participating Broker-Dealers holding not less than a majority in
aggregate principal amount of the Exchange Notes held by all Participating Broker-Dealers; provided, however, that
Section 7 and this Section 10(c) may not be amended, modified or supplemented without the prior written consent of each
Holder and each Participating Broker-Dealer (including any person who was a Holder or Participating Broker-Dealer of Registrable
Notes or Exchange Notes, as the case may be, disposed of pursuant to any Registration Statement) affected by any such amendment,
modification or supplement. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect
to a matter that relates exclusively to the rights of other Holders of Registrable Notes whose securities are being sold pursuant
to a Registration Statement and that does not directly or indirectly affect, impair, limit or compromise the rights of Holders
of Registrable Notes not being sold pursuant to such Registration Statement may be given by Holders of at least a majority in
aggregate principal amount of the Registrable Notes being sold pursuant to such Registration Statement.

 

(d)         Notices.  All notices and other
communications (including, without limitation, any notices or other communications to the Trustee) provided for or permitted hereunder
shall be made in writing by hand-delivery, registered first-class mail, next-day air courier or facsimile:

 

(i)          if to a Holder of the
Registrable Notes or any Participating Broker-Dealer, at the most current address of such Holder or Participating Broker-Dealer,
as the case may be, set forth on the records of the registrar under the Indenture, with a copy in like manner to the Initial Purchasers
as follows:

 

J.P. Morgan Securities LLC

383 Madison Avenue

New York, New York 10179

Telephone:  (212) 834-4533

Facsimile:  (212) 834-6081

Attn:  Investment Grade Syndicate Desk

 

with a copy to:

 

Cahill
Gordon & Reindel LLP

80 Pine Street

New York, New York 10005

Facsimile No.:  (212) 378-2198

Attention:  Stuart Downing, Esq.

 

    	-28-

    	 

    

 

(ii)         if to the Initial Purchasers,
at the address specified in Section 10(d)(i); and

 

(iii)        if to the Company, at
the address as follows:

 

			Omega Healthcare Investors, Inc.

			200 International Circle

Suite
3500

Hunt Valley, MD  21030

Facsimile No.:  (410) 427-8822

Attention:  Robert O. Stephenson

 

with a copy to:

 

Bryan Cave LLP

One Atlantic Center, Fourteenth Floor

1201 W. Peachtree Street, NW

Atlanta,
Georgia  30309-3488

Facsimile No.:  (404) 420-0785

Attention:  Eliot W. Robinson, Esq.

 

All such notices and communications shall
be deemed to have been duly given: when delivered by hand, if personally delivered; five Business Days after being deposited in
the mail, postage prepaid, if mailed; one Business Day after being timely delivered to a next-day air courier; and upon written
confirmation, if sent by facsimile.

 

Copies of all such notices, demands or other
communications shall be concurrently delivered by the Person giving the same to the Trustee at the address and in the manner specified
in such Indenture.

 

(e)         Successors and Assigns.  This
Agreement shall inure to the benefit of and be binding upon the successors and assigns of each of the parties hereto, the Holders
and the Participating Broker-Dealers; provided, however, that nothing herein shall be deemed to permit any assignment,
transfer or other disposition of Registrable Notes in violation of the terms of the Purchase Agreement or the Indenture.

 

(f)          Counterparts.  This Agreement
may be executed in any number of counterparts and by the parties hereto in separate counterparts, each of which when so executed
shall be deemed to be an original and all of which taken together shall constitute one and the same agreement.

 

(g)         Headings.  The headings in this
Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

    	-29-

    	 

    

 

(h)        Governing Law.  THIS AGREEMENT
SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO CONTRACTS MADE AND PERFORMED
ENTIRELY WITHIN THE STATE OF NEW YORK, WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW THAT WOULD REQUIRE THE APPLICATION OF
ANY OTHER LAW.

 

(i)          Severability.  If any term,
provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void
or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force
and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially reasonable
efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such
term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would
have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter
declared invalid, illegal, void or unenforceable.

 

(j)          Notes Held by the Issuers or Their
Affiliates.  Whenever the consent or approval of Holders of a specified percentage of Registrable Notes is required hereunder,
Registrable Notes held by the Issuers or their affiliates (as such term is defined in Rule 405 under the Securities Act)
shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage.

 

(k)         Third-Party Beneficiaries.
 Holders of Registrable Notes and Participating Broker-Dealers are intended third-party beneficiaries of this Agreement, and this
Agreement may be enforced by such Persons.

 

(l)          Entire Agreement.  This Agreement,
together with the Purchase Agreement and the Indenture, is intended by the parties as a final and exclusive statement of the agreement
and understanding of the parties hereto in respect of the subject matter contained herein and therein and any and all prior oral
or written agreements, representations, or warranties, contracts, understandings, correspondence, conversations and memoranda
between the Holders on the one hand and the Issuers on the other, or between or among any agents, representatives, parents, subsidiaries,
affiliates, predecessors in interest or successors in interest with respect to the subject matter hereof and thereof are merged
herein and replaced hereby.

 

[Signature Pages Follow]

 

    	-30-

    	 

    

 

IN WITNESS WHEREOF, the parties have executed
this Agreement as of the date first written above.

 

	 	OMEGA HEALTHCARE INVESTORS, INC.,
	 	as Issuer
	 	By:	/s/ Robert O. Stephenson
	 	 	Name: 	Robert O. Stephenson
	 	 	Title:	Chief Financial Officer and Treasurer

 

    	 

    	 

    

 

	 	1200 Ely Street Holdings
    Co. LLC
	 	13922 CErise avenue, llc
	 	2425 teller avenue, llc
	 	245 East Wilshire avenue,
    llc
	 	3806 CLAYTON ROAD, LLC
	 	42235 County Road Holdings
    Co. LLC
	 	48 HIGH POINT ROAD, LLC
	 	523 HAYES LANE, LLC
	 	637 EAST ROMIE LANE, LLC
	 	Arizona Lessor - Infinia,
    Inc.
	 	Bayside Colorado Healthcare
    Associates, Inc.
	 	Bayside Street II, Inc.
	 	Bayside Street, Inc.
	 	Canton Health Care Land,
    Inc. 
	 	Carnegie Gardens LLC
	 	CFG 2115 Woodstock Place
    LLC
	 	Colonial Gardens, LLC 
	 	Colorado Lessor - Conifer,
    Inc.
	 	CSE Albany LLC
	 	CSE Amarillo LLC
	 	CSE Arden L.P.
	 	CSE Augusta LLC
	 	CSE Bedford LLC
	 	CSE Blountville LLC
	 	CSE Bolivar LLC
	 	CSE Cambridge LLC
	 	CSE Cambridge Realty LLC
	 	CSE Camden LLC
	 	CSE Canton LLC
	 	CSE Casablanca Holdings
    II LLC
	 	CSE Casablanca Holdings
    LLC
	 	CSE Cedar Rapids LLC
	 	CSE Centennial Village
	 	CSE Chelmsford LLC
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	CSE Chesterton LLC,
	 	CSE Claremont LLC
	 	CSE Corpus North LLC
	 	CSE Denver Iliff LLC
	 	CSE Denver LLC
	 	CSE Douglas LLC
	 	CSE Elkton LLC
	 	CSE Elkton Realty LLC
	 	CSE Fairhaven LLC
	 	CSE Fort Wayne LLC
	 	CSE Frankston LLC
	 	CSE Georgetown LLC
	 	CSE Green Bay LLC
	 	CSE Hilliard LLC
	 	CSE Huntingdon LLC
	 	CSE Huntsville LLC
	 	CSE Indianapolis-Continental
    LLC
	 	CSE Indianapolis-Greenbriar
    LLC
	 	CSE Jacinto City LLC
	 	CSE Jefferson City LLC
	 	CSE Jeffersonville-Hillcrest
    Center LLC
	 	CSE Jeffersonville-Jennings
    House LLC
	 	CSE Kerrville LLC
	 	CSE King L.P.
	 	CSE Kingsport LLC
	 	CSE Knightdale L.P.
	 	CSE Lake City LLC
	 	CSE Lake Worth LLC
	 	CSE Lakewood LLC
	 	CSE Las Vegas LLC
	 	CSE Lawrenceburg LLC
	 	CSE Lenoir L.P.
	 	CSE Lexington Park LLC
	 	CSE Lexington Park Realty
    LLC
	 	CSE Ligonier LLC
	 	CSE Live Oak LLC,
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	CSE Lowell LLC
	 	CSE Marianna Holdings LLC
	 	CSE Memphis LLC
	 	CSE Mobile LLC
	 	CSE Moore LLC
	 	CSE North Carolina Holdings
    I LLC
	 	CSE North Carolina Holdings
    II LLC
	 	CSE Omro LLC
	 	CSE Orange Park LLC
	 	CSE Orlando-Pinar Terrace
    Manor LLC
	 	CSE Orlando-Terra Vista
    Rehab LLC
	 	CSE Pennsylvania Holdings
	 	CSE Piggott LLC
	 	CSE Pilot Point LLC
	 	CSE Pine View LLC
	 	CSE Ponca City LLC
	 	CSE Port St. Lucie LLC
	 	CSE Richmond LLC
	 	CSE Ripley LLC
	 	CSE Ripon LLC
	 	CSE Safford LLC
	 	CSE Salina LLC
	 	CSE Seminole LLC
	 	CSE Shawnee LLC
	 	CSE Spring Branch LLC
	 	CSE Stillwater LLC
	 	CSE Taylorsville LLC
	 	CSE Texarkana LLC
	 	CSE Texas City LLC
	 	CSE The Village LLC
	 	CSE Upland LLC
	 	CSE Walnut Cove L.P.
	 	CSE West Point LLC
	 	CSE Whitehouse LLC
	 	CSE Williamsport LLC
	 	CSE Winter Haven LLC,
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	CSE Woodfin L.P.
	 	CSE Yorktown LLC
	 	Delta Investors I, LLC
	 	Delta Investors II, LLC
	 	Desert Lane LLC
	 	Dixie White House Nursing
    Home, Inc.
	 	Dixon Health Care Center,
    Inc. 
	 	Encanto Senior Care, LLC
	 	Florida Lessor – Meadowview,
    Inc.
	 	Florida Real Estate Company,
    LLC
	 	Georgia Lessor - Bonterra/Parkview,
    Inc.
	 	Greenbough, LLC
	 	Hutton I Land, Inc. 
	 	Hutton II Land, Inc. 
	 	Hutton III Land, Inc. 
	 	Indiana Lessor – Wellington
    Manor, Inc.
	 	LAD I Real Estate Company,
    LLC
	 	Leatherman 90-1, Inc. 
	 	Leatherman Partnership 89-1,
    Inc. 
	 	Leatherman Partnership 89-2,
    Inc. 
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	Meridian Arms
    Land, Inc. 
	 	North Las Vegas LLC
	 	NRS Ventures, L.L.C.
	 	Ocean Springs Nursing Home,
    Inc.
	 	OHI (Connecticut), Inc.
    
	 	OHI (Illinois), Inc. 
	 	OHI (Indiana), Inc. 
	 	OHI (Iowa), Inc. 
	 	OHI Asset (AR) Ash Flat,
    LLC
	 	OHI Asset (AR) Camden, LLC
	 	OHI Asset (AR) Conway, LLC
	 	OHI Asset (AR) Des Arc,
    LLC
	 	OHI Asset (AR) Hot Springs,
    LLC
	 	OHI Asset (AR) Malvern,
    LLC
	 	OHI Asset (AR) Mena, LLC
	 	OHI Asset (AR) Pocahontas,
    LLC
	 	OHI Asset (AR) Sheridan,
    LLC
	 	OHI Asset (AR) Walnut Ridge,
    LLC
	 	OHI Asset (AZ) Austin House,
    LLC
	 	OHI Asset (CA), LLC
	 	OHI Asset (CO), LLC
	 	OHI Asset (CT) Lender, LLC
	 	OHI Asset (FL) Lake Placid,
    LLC
	 	OHI Asset (FL) Lender, LLC
	 	OHI Asset (FL), LLC
	 	OHI ASSET (GA) MACON, LLC
	 	OHI Asset (GA) Moultrie,
    LLC
	 	OHI Asset (GA) Snellville,
    LLC
	 	OHI Asset (ID) Holly, LLC
	 	OHI Asset (ID) Midland,
    LLC
	 	OHI Asset (ID), LLC
	 	OHI Asset (IL), LLC
	 	OHI Asset (IN) American
    Village, LLC
	 	OHI Asset (IN) Anderson,
    LLC,
	 	as Subsidiary Guarantors
	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	OHI Asset (IN) Beech Grove,
    LLC
	 	OHI Asset (IN) Clarksville,
    LLC
	 	OHI Asset (IN) Clinton,
    LLC
	 	OHI Asset (IN) Connersville,
    LLC
	 	OHI Asset (IN) Crown Point,
    LLC
	 	OHI Asset (IN) Eagle Valley,
    LLC
	 	OHI Asset (IN) Elkhart,
    LLC
	 	OHI Asset (IN) Forest Creek,
    LLC
	 	OHI Asset (IN) Fort Wayne,
    LLC
	 	OHI Asset (IN) Franklin,
    LLC
	 	OHI Asset (IN) Greensburg,
    LLC
	 	OHI Asset (IN) Indianapolis,
    LLC
	 	OHI Asset (IN) Jasper, LLC
	 	OHI Asset (IN) Kokomo, LLC
	 	OHI Asset (IN) Lafayette,
    LLC
	 	OHI Asset (IN) Madison,
    LLC
	 	OHI Asset (IN) Monticello,
    LLC
	 	OHI Asset (IN) Noblesville,
    LLC
	 	OHI Asset (IN) Rosewalk,
    LLC
	 	OHI Asset (IN) Salem, LLC
	 	OHI Asset (IN) Seymour,
    LLC
	 	OHI Asset (IN) Spring Mill,
    LLC
	 	OHI Asset (IN) Terre Haute,
    LLC
	 	OHI Asset (IN) Wabash, LLC
	 	OHI Asset (IN) Westfield,
    LLC
	 	OHI Asset (IN) Zionsville,
    LLC
	 	OHI Asset (LA), LLC
	 	OHI Asset (MD), LLC
	 	OHI Asset (MI) Heather Hills,
    LLC
	 	OHI Asset (MI), LLC
	 	OHI Asset (MO), LLC
	 	OHI Asset (MS) Byhalia,
    LLC
	 	OHI Asset (MS) Cleveland,
    LLC
	 	OHI Asset (MS) Clinton,
    LLC
	 	OHI Asset (MS) Columbia,
    LLC,
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	OHI Asset (MS) Corinth,
    LLC
	 	OHI Asset (MS) Greenwood,
    LLC
	 	OHI Asset (MS) Grenada,
    LLC
	 	OHI Asset (MS) Holly Springs,
    LLC
	 	OHI Asset (MS) Indianola,
    LLC
	 	OHI Asset (MS) Natchez,
    LLC
	 	OHI Asset (MS) Picayune,
    LLC
	 	OHI Asset (MS) Vicksburg,
    LLC
	 	OHI Asset (MS) Yazoo City,
    LLC
	 	OHI Asset (NC) Wadesboro,
    LLC
	 	OHI Asset (OH) Lender, LLC
	 	OHI Asset (OH), LLC
	 	OHI Asset (OR) Portland,
    LLC
	 	OHI Asset (PA) Trust
	 	OHI Asset (PA), LLC
	 	OHI Asset (SC) Aiken, LLC
	 	OHI Asset (SC) Anderson,
    LLC
	 	OHI Asset (SC) Easley Anne,
    LLC
	 	OHI Asset (SC) Easley Crestview,
    LLC
	 	OHI Asset (SC) Edgefield,
    LLC
	 	OHI ASSET (SC) Greenville,
    LLC
	 	OHI Asset (SC) Greenville
    Griffith, LLC
	 	OHI Asset (SC) Greenville
    Laurens, LLC
	 	OHI Asset (SC) Greenville
    North, LLC
	 	OHI Asset (SC) Greer, LLC
	 	OHI Asset (SC) Marietta,
    LLC
	 	OHI Asset (SC) McCormick,
    LLC
	 	OHI ASSET (SC) orangeburg,
    LLC
	 	OHI Asset (SC) Pickens East
    Cedar, LLC
	 	OHI Asset (SC) Pickens Rosemond,
    LLC
	 	OHI Asset (SC) Piedmont,
    LLC
	 	OHI Asset (SC) Simpsonville
    SE Main, LLC,
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	OHI Asset (SC) Simpsonville
    West Broad, LLC
	 	OHI Asset (SC) Simpsonville
    West Curtis, LLC
	 	OHI Asset (TN) Bartlett,
    LLC
	 	OHI Asset (TN) Collierville,
    LLC
	 	OHI Asset (TN) Memphis,
    LLC
	 	OHI Asset (TX) Anderson,
    LLC
	 	OHI Asset (TX) Bryan, LLC
	 	OHI Asset (TX) Burleson,
    LLC
	 	OHI Asset (TX) College Station,
    LLC
	 	OHI Asset (TX) Comfort,
    LLC
	 	OHI Asset (TX) Diboll, LLC
	 	OHI Asset (TX) Granbury,
    LLC
	 	OHI Asset (TX) Hondo, LLC
	 	OHI Asset (TX) Italy, LLC
	 	OHI Asset (TX) Winnsboro,
    LLC
	 	OHI Asset (TX), LLC
	 	OHI Asset (UT) Ogden, LLC
	 	OHI Asset (UT) Provo, LLC
	 	OHI Asset (UT) Roy, LLC
	 	OHI Asset (VA) Charlottesville,
    LLC
	 	OHI Asset (VA) Farmville,
    LLC
	 	OHI Asset (VA) Hillsville,
    LLC
	 	OHI Asset (VA) Rocky Mount,
    LLC
	 	OHI Asset (WA) Battle Ground,
    LLC
	 	ohi asset (Wv) danville,
    llc
	 	ohi asset (Wv) ivydale,
    llc
	 	OHI Asset CSB LLC
	 	OHI Asset CSE – E,
    LLC
	 	OHI Asset CSE – U,
    LLC
	 	OHI Asset HUD CFG, LLC
	 	OHI Asset HUD Delta, LLC
	 	OHI Asset HUD SF CA, LLC
	 	OHI Asset HUD SF, LLC
	 	OHI Asset HUD WO, LLC
	 	OHI Asset II (CA), LLC,
	 	as Subsidiary Guarantors
	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary and Secretary

 

    	 

    	 

    

 

	 	OHI Asset II (FL), LLC
	 	OHI Asset II (PA) Trust
	 	OHI Asset III (PA) Trust
	 	OHI Asset IV (PA) Silver
    Lake Trust
	 	OHI Asset RO PMM Services,
    LLC
	 	OHI Asset RO, LLC
	 	OHI Asset, LLC
	 	OHI Mezz Lender, LLC
	 	OHI Tennessee, Inc.
	 	OHIMA, Inc.
	 	Omega TRS I, Inc.
	 	Orange Village Care Center,
    Inc.
	 	Panama City Nursing Center
    LLC
	 	Pavillion North Partners,
    Inc.
	 	Pavillion North, LLP
	 	Pavillion Nursing Center
    North, Inc.
	 	Pensacola Real Estate Holdings
    I, Inc.
	 	Pensacola Real Estate Holdings
    II, Inc.
	 	Pensacola Real Estate Holdings
    III, Inc.
	 	Pensacola Real Estate Holdings
    IV, Inc.
	 	Pensacola Real Estate Holdings
    V, Inc.
	 	Skyler Boyington, Inc.
	 	Skyler Florida, Inc.
	 	Skyler Maitland LLC
	 	Skyler Pensacola, Inc.
	 	St. Mary’s Properties,
    Inc.
	 	Sterling Acquisition Corp.,
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

	 	Suwanee, LLC
	 	Texas Lessor – Stonegate
    GP, Inc.
	 	Texas Lessor – Stonegate,
    Limited, Inc.
	 	Texas Lessor – Stonegate,
    LP
	 	The Suburban Pavilion, Inc.
    
	 	Washington Lessor –
    Silverdale, Inc.
	 	Wilcare, LLC, 
	 	as Subsidiary Guarantors
	 	 	 	 
	 	By:	/s/ Daniel J. Booth 
	 	 	Name:	Daniel J. Booth
	 	 	Title:	Chief Operating Officer and Secretary

 

    	 

    	 

    

 

The foregoing Agreement is hereby

confirmed and accepted as of the date

first above written.

 

J.P. MORGAN SECURITIES LLC

MERRILL LYNCH, PIERCE, FENNER
& SMITH INCORPORATED

CREDIT AGRICOLE SECURITIES (USA) INC.

RBS SECURITIES INC.

BB&T CAPITAL MARKETS, A DIVISION OF BB&T SECURITIES,
LLC

CAPITAL ONE SECURITIES, INC.

MITSUBISHI UFJ SECURITIES (USA), INC.

MORGAN STANLEY & CO. LLC

RBC CAPITAL MARKETS, LLC

SMBC NIKKO SECURITIES AMERICA, INC.

STIFEL, NICOLAUS & COMPANY, INCORPORATED

SUNTRUST ROBINSON HUMPHREY, INC.

 

		By:	J.P. MORGAN SECURITIES LLC

Acting on behalf of itself and
as

Representative of the several Initial

Purchasers

 

	By:	/s/ Stephen L. Scheiner	 
	 	Name: Stephen L. Sheiner	 
	 	Title: Executive Director	 

 

    	 

    	 

    

 

	MERRILL LYNCH, PIERCE, FENNER
    & SMITH	 
	 	INCORPORATED	 
	 	 	 
	By:	/s/ Shawn Cepeda	 
	 	Name: Shawn Cepeda	 
	 	Title: Managing Director	 

 

    	 

    	 

    

 

	CREDIT AGRICOLE SECURITIES
    (USA) INC.	 
	 	 	 
	By:	/s/ Mike Kendrot	 
	 	Name: Mike Kendrot	 
	 	Title: Head of DCM Origination, Americas	 

 

    	 

    	 

    

 

	RBS SECURITIES INC.	 
	 	 
	By:	/s/ Collin Sawson	 
	 	Name: Collin Sawson	 
	 	Title: Director	 

 

    	 

    	 

    

 

EXHIBIT A

 

PLAN OF DISTRIBUTION

 

Each Participating Broker-Dealer that receives
Exchange Notes for its own account pursuant to the Exchange Offer must acknowledge that it will deliver a prospectus in connection
with any resale of such Exchange Notes during the Applicable Period. This Prospectus, as it may be amended or supplemented from
time to time, may be used by a Participating Broker-Dealer in connection with resales of Exchange Notes received in exchange for
Notes where such Notes were acquired as a result of market-making activities or other trading activities. The Company has agreed
that, during the Applicable Period, it will make this Prospectus, as amended or supplemented, available to any Participating Broker-Dealer
for use in connection with any such resale. In addition, until ____________, all dealers effecting transactions in the Exchange
Notes may be required to deliver a prospectus.

 

The Company will not receive any proceeds
from any sale of Exchange Notes by Participating Broker-Dealers. Exchange Notes received by Participating Broker-Dealers for their
own account pursuant to the Exchange Offer may be sold from time to time in one or more transactions in the over-the-counter market,
in negotiated transactions, through the writing of options on the Exchange Notes or a combination of such methods of resale, at
market prices prevailing at the time of resale, at prices related to such prevailing market prices or negotiated prices. Any such
resale may be made directly to purchasers or to or through brokers or dealers who may receive compensation in the form of commissions
or concessions from any such Participating Broker-Dealer and/or the purchasers of any such Exchange Notes. Any Participating Broker-Dealer
that resells Exchange Notes that were received by it for its own account pursuant to the Exchange Offer and any broker or dealer
that participates in a distribution of such Exchange Notes may be deemed to be an “underwriter” within the meaning
of the Act and any profit from any such resale of Exchange Notes and any commissions or concessions received by any such persons
may be deemed to be underwriting compensation under the Act. The letter of transmittal states that by acknowledging that it will
deliver and by delivering a prospectus, a Participating Broker-Dealer will not be deemed to admit that it is an “underwriter”
within the meaning of the Act.

 

During the Applicable Period, the Company
will promptly send additional copies of this Prospectus and any amendment or supplement to this Prospectus to any Participating
Broker-Dealer that requests such documents in the letter of transmittal. The Company has agreed to pay all expenses incident to
the Exchange Offer other than dealers’ and brokers’ discounts, commissions and counsel fees and will indemnify the
holders of the Notes (including any Participating Broker-Dealer) against certain liabilities, including liabilities under the
Act.

 

[If applicable, add information required
by Regulation S-K Items 507 and/or 508.]

 

    	A-1EX-4.2

 Exhibit 4.2 

FOURTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

THIS FOURTH AMENDED AND RESTATED INVESTOR
RIGHTS AGREEMENT (this “Agreement”) is entered into as of January 12, 2012, by and among Mevion Medical Systems, Inc., a Delaware corporation (together with all of its
subsidiaries, the “Company”), and the investors listed on Exhibit A hereto and each person who shall join in and become a party to this Agreement by executing and delivering to the Company an Instrument of Accession in
the form of Schedule I attached hereto. Such persons collectively are referred to hereinafter as the “Investors” and each individually as an “Investor.” 

RECITALS 

WHEREAS, the Company and certain of the Investors entered into an Investor Rights Agreement dated as of
April 29, 2005 (the “Original Investor Rights Agreement”) in connection with the purchase by such Investors of the Company’s Series A Convertible Preferred Stock, par value $0.01 per share (the “Series A Preferred
Stock”); 
 WHEREAS, the Company and certain of the Investors amended and restated the
Original Investor Rights Agreement on April 7, 2006 (the “Amended and Restated Investor Rights Agreement”) in connection with the purchase by such Investors of the Company’s Series B Convertible Preferred Stock, par value
$0.01 per share (the “Series B Preferred Stock”); 
 WHEREAS, the Company and certain
of the Investors amended and restated the Amended and Restated Investor Rights Agreement on September 5, 2007, and further amended the terms thereof on March 14, 2008 (the “Second Amended and Restated Investor Rights
Agreement”) in connection with the purchase by such Investors of the Company’s Series C Convertible Preferred Stock, par value $0.01 per share (the “Series C Preferred Stock”); 

WHEREAS, the Company and certain of the Investors amended and restated the Second Amended and Restated
Investor Rights Agreement on February 17, 2009, and further amended the terms thereof on September 20, 2010 (the “Third Amended and Restated Investor Rights Agreement”) in connection with the purchase by such Investors of
the Company’s Series D Convertible Preferred Stock, par value $0.01 per share (the “Series D Preferred Stock”) and Series D-1 Convertible Preferred Stock, par value $0.01 per share (the “Series D-1 Preferred
Stock”); 
 WHEREAS, the Company and the Investors are entering into concurrently herewith a Series E
Convertible Preferred Stock Purchase Agreement of even date herewith (the “Series E Purchase Agreement”) in connection with the purchase by such Investors of the Company’s Series E Convertible Preferred Stock, par value $0.01
per share (the “Series E Preferred Stock”); 
 WHEREAS, in connection with the Series
E Purchase Agreement, the Company and the undersigned parties to the Third Amended and Restated Investor Rights Agreement, representing the Requisite Vote (as defined therein) and acting pursuant to Section 15(d) of the Third Amended and
Restated Investor Rights Agreement, desire to amend and restate the Third Amended and Restated Investor Rights Agreement in its entirety to read as set forth in this Agreement; and 

WHEREAS, this amendment and restatement shall be binding upon all parties to the Third Amended and Restated Investor
Rights Agreement upon the execution of this Agreement by the Company and the Requisite Vote pursuant to Section 15(d) of the Third Amended and Restated Investor Rights Agreement. 

  
 1. 

 NOW, THEREFORE, in consideration of the mutual covenants
herein contained and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows: 

1. General. 

(a) This Agreement amends, restates and replaces the Third Amended and Restated Investor Rights Agreement in its entirety, and
upon execution of this Agreement, the Third Amended and Restated Investor Rights Agreement shall no longer be of any force or effect. 

(b) Certain Definitions. As used in this Agreement, the terms below shall have the following respective meanings: 

“Board of Directors” shall mean the board of directors of the Company as constituted from time to time. 

“Certificate of Incorporation” shall mean the Company’s Sixth Amended and Restated Certificate of Incorporation, as the
same may be amended, restated or otherwise modified from time to time. 
 “Code” shall mean the Internal Revenue Code of
1986, as amended from time to time. 
 “Commission” shall mean the Securities and Exchange Commission, or any other
federal agency at the time administering the Securities Act. 
 “Common Stock” shall mean the Common Stock, $0.001 par
value, of the Company, as constituted as of the date of this Agreement. 
 “Conversion Shares” shall mean shares of Common
Stock issued or issuable upon conversion of the Preferred Shares. 
 “ERISA” shall mean the Employee Retirement Income
Security Act of 1974, as amended. 
 “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, or any
similar federal statute, and the rules and regulations of the Commission thereunder, all as the same shall be in effect at the time. 

“Indebtedness” shall mean all obligations, contingent and otherwise, which should, in accordance with generally accepted
accounting principles, be classified upon the obligor’s balance sheet (or the notes thereto) as liabilities (other than trade credit incurred in the ordinary course of business), but in any event including liabilities secured by any mortgage on
property owned or acquired subject to such mortgage, whether or not the liability secured 

  
 2 

 
thereby shall have been assumed, and also including (i) all guaranties, endorsements and other contingent obligations, in respect of Indebtedness of others, whether or not the same are or
should be so reflected in said balance sheet (or the notes thereto) and (ii) the present value of any lease payments due under leases required to be capitalized in accordance with applicable Statements of Financial Accounting Standards,
determined by discounting all such payments at the interest rate determined in accordance with applicable Statements of Financial Accounting Standards. 

“Intellectual Property Rights” shall mean all of the following: (i) patents, patent applications, patent disclosures
and all related continuation, continuation-in-part, divisional, reissue, re-examination, utility, model, certificate of invention and design patents, patent applications, registrations and applications for registrations, (ii) trademarks,
service marks, trade dress, logos, tradenames, service names and corporate names and registrations and applications for registration thereof, (iii) copyrights and registrations and applications for registration thereof, (iv) mask works and
registrations and applications for registrations thereof, (v) trade secrets and confidential business information, whether patentable or nonpatentable and whether or not reduced to practice, know-how, manufacturing and product processes and
techniques, research and development information, copyrightable works, financial, marketing and business data, pricing and cost information, business and marketing plans and customer and supplier lists and information, (vi) other proprietary
rights relating to any of the foregoing (including without limitation associated goodwill and remedies against infringements thereof and rights of protection of an interest therein under the laws of all jurisdictions) and (vii) copies and
tangible embodiments thereof. 
 “IPO” shall mean the Company’s first underwritten public offering of its Common
Stock under the Securities Act. 
 “Key Employee” or “Key Employees” shall mean and include the President, chief
executive officer, chief financial officer, chief operating officer, chief technology officer, vice presidents of operations, research, development, sales or marketing, or any other individual who performs a significant role in the operations of the
Company or a Subsidiary. 
 “Major Investors” shall mean any Investor holding (i) Shares of Series E Preferred Stock
and (ii) more than 5% of the issued and outstanding shares of Preferred Stock (determined on an as-converted to Common Stock basis). 

“Person or Persons” shall mean an individual, corporation, partnership, limited liability company, joint venture, trust, or
unincorporated organization, or a government or any agency or political subdivision thereof. 
 “Preferred Director” shall
mean the Series E Preferred Director, the Series D Preferred Directors and the Series A/B/C Preferred Directors. 
 “Preferred
Shares” shall mean shares of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series D-1 Preferred Stock and Series E Preferred Stock. 

  
 3 

 “Qualified Initial Public Offering” shall mean the Company’s first, fully
underwritten, firm commitment public offering pursuant to an effective registration under the Securities Act covering the offer and sale by the Company of its Common Stock in which (i) the aggregate proceeds to the Company equal or exceed
$50,000,000 and (ii) the price paid by the public for such shares shall be at least three times the price originally paid for the shares of Series E Preferred Stock (subject to appropriate adjustment to reflect any stock split, stock dividend,
reverse stock split or similar corporate event affecting the shares of Series E Preferred Stock). 
 “Registration
Expenses” shall mean the expenses so described in Section 8. 
 “Requisite Vote” shall mean the
approval, consent or waiver, as applicable, given in writing or by a vote at a meeting (as the case may be) by (i) the holders of more than fifty-six percent (56%) of the outstanding shares of Preferred Stock (determined on an as-converted
basis) and (ii) at least two of the following Investors: (a) CHLS (Still River) LLC, (b) Venrock Healthcare Capital Partners, L.P., (c) CHL Medical Partners III, L.P. and (d) ProQuest Investments IV, L.P.
(“ProQuest”); provided, however, that if ProQuest fails to purchase its Pro Rata Portion at a Subsequent Closing or its Pro Rata Amount at a Qualified Financing (which shall include for this purpose (x) the
failure of ProQuest to respond within the time periods specified herein that it will purchase its Pro Rata Amount in any such Qualified Financing or (y) an indication from ProQuest in writing that it does not intend to participate in any such
Qualified Financing), clause (y) above shall no longer apply such that the term “Requisite Vote” shall mean the holders of more than fifty-six percent (56%) of the outstanding shares of Preferred Stock (determined on an
as-converted basis). 
 “Reserved Employee Shares” shall mean shares of Common Stock not to exceed in the aggregate
885,902 shares (appropriately adjusted to reflect stock splits, stock dividends, combinations of shares and the like with respect to the Common Stock) reserved by the Company for issuance pursuant to stock purchase, stock grant or stock option
arrangements for employees, directors or consultants of the Company, all under arrangements approved by the Board of Directors. The foregoing number of Reserved Employee Shares may be increased by vote or written consent of the Board of Directors
(which shall include the vote or written consent of at least one director appointed by the Investors). 
 “Restricted
Stock” shall mean the (a) Conversion Shares and (b) any Common Stock, or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the Company, acquired by the
Investors, excluding, in each case, Conversion Shares which have been (i) registered under the Securities Act pursuant to an effective registration statement filed thereunder and disposed of in accordance with the registration statement
covering them or (ii) publicly sold pursuant to Rule 144. 
 “Rule 144” shall mean Rule 144 promulgated by the
Commission under the Securities Act. 

  
 4 

 “Series A/B/C Preferred Director” shall mean the directors of the Company
elected by the holders of Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock, voting together as one class on an as-converted basis. 

“Series D Preferred Director” shall mean the directors of the Company elected by the holders of Series D Preferred Stock and
Series D-1 Preferred Stock, voting together as one class on an as-converted basis. 
 “Series E Preferred Director” shall
mean the directors of the Company elected by the holders of Series E Preferred Stock, voting together as one class on an as-converted basis. 

“Securities Act” shall mean the Securities Act of 1933, as amended, or any similar federal statute, and the rules and
regulations of the Commission thereunder, all as the same shall be in effect at the time. 
 “Selling
Expenses” shall mean the expenses so described in Section 8. 
 “Subsidiary” or
“Subsidiaries” shall mean any corporation, trust or other entity of which the Company and/or any of its other Subsidiaries (as herein defined) directly or indirectly owns at the time outstanding shares of every class of such
corporation, trust or other entity other than directors’ qualifying shares comprising at least fifty percent (50%) of the voting power of such corporation, trust or other entity. 

2. Restrictive Legend. Each certificate representing Preferred Shares, Conversion Shares or Restricted Stock shall, except as otherwise
provided in this Section 2 or in Section 3, be stamped or otherwise imprinted with a legend substantially in the following form: 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE SECURITIES
LAWS. THESE SECURITIES HAVE BEEN ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO DISTRIBUTION OR RESALE, AND MAY NOT BE SOLD, MORTGAGED, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES
UNDER THE SECURITIES ACT OF 1933 AND APPLICABLE STATE SECURITIES LAWS, OR THE AVAILABILITY OF AN EXEMPTION FROM THE REGISTRATION PROVISIONS OF THE SECURITIES ACT OF 1933 AND APPLICABLE STATE SECURITIES LAWS.” 

A certificate shall not bear such legend if in the opinion of counsel satisfactory to the Company (it being agreed that the opinion of Goodwin Procter LLP,
among others, shall be satisfactory) the securities represented thereby may be publicly sold without registration under the Securities Act and any applicable state securities laws. 

3. Notice of Proposed Transfer. Prior to any proposed transfer of any Preferred Shares, Conversion Shares or Restricted Stock (other
than under the circumstances described in Sections 4, 5 or 6), the holder thereof shall give written notice to the Company of its intention to effect such transfer. Each such notice shall describe the manner of the proposed
transfer and, if 

  
 5 

 
requested by the Company, shall be accompanied by an opinion of counsel satisfactory to the Company (it being agreed that the opinion of Goodwin Procter LLP, among others shall be satisfactory)
to the effect that the proposed transfer may be effected without registration under the Securities Act and any applicable state securities laws, whereupon the holder of such stock shall be entitled to transfer such stock in accordance with the terms
of its notice; provided, however, that no such opinion of counsel shall be required for a transfer to one or more partners, former partners, members or former members of the transferor (in the case of a transferor that is a partnership
or a limited liability company, respectively) or to an affiliated entity (in the case of a transferor that is an entity) for no consideration; provided, further, however, that any such transferee shall execute and deliver
to the Company a representation letter in form reasonably satisfactory to the Company’s counsel to the effect that the transferee is acquiring such shares for its own account, for investment purposes and without any view to distribution
thereof. Each certificate for Preferred Shares, Conversion Shares or Restricted Stock transferred as above provided shall bear the legend set forth in Section 2, except that such certificate shall not bear such legend if (i) such
transfer is in accordance with the provisions of Rule 144 (or any other rule permitting public sale without registration under the Securities Act) or (ii) the opinion of counsel referred to above is to the further effect that the
transferee and any subsequent transferee (other than an affiliate of the Company) would be entitled to transfer such securities in a public sale without registration under the Securities Act. 

4. Required Registration. 

(a) At any time after the earlier of (i) five (5) years after the date hereof, or (ii) 180 days after an IPO,
the holders of Restricted Stock constituting at least 40% in interest of the total shares of Restricted Stock then outstanding may request the Company to register under the Securities Act the shares of Restricted Stock held by such requesting holder
or holders for sale in the manner specified in such notice, provided that the offering has an anticipated aggregate offering price that exceeds $15,000,000. For purposes of this Section 4 and Sections 5, 6,
15(a) and 15(f), the term “Restricted Stock” shall be deemed to include the number of shares of Restricted Stock which would be issuable to a holder of Preferred Shares upon conversion of all Preferred Shares;
provided, however, that the only securities which the Company shall be required to register pursuant hereto shall be shares of Common Stock; provided, further, however, that, in any underwritten public offering
contemplated by this Section 4 or Sections 5 and 6, the holders of Preferred Shares shall be entitled to sell such Preferred Shares to the underwriters for conversion and sale of the shares of Common Stock issued upon
conversion or exercise and conversion, as applicable, thereof. Notwithstanding anything to the contrary contained herein, no request may be made under this Section 4 within 180 days after the effective date of any registration
statement on Form S-1 filed by the Company; provided that holders of Restricted Stock have been provided the opportunity to register their respective shares of Restricted Stock held by them pursuant to Section 5 of this Agreement. 

(b) Following receipt of any notice under this Section 4, the Company shall immediately notify all holders of
Restricted Stock and Preferred Shares from whom notice has not been received and such holders shall then be entitled within 30 days thereafter to request the Company to include in the requested registration all or any

  
 6 

 
portion of their shares of Restricted Stock. The Company shall use its reasonable best efforts to register under the Securities Act, for public sale in accordance with the method of disposition
described in paragraph (a) above, the number of shares of Restricted Stock specified in such notice (and in all notices received by the Company from other holders within 30 days after the giving of such notice by the Company). The Company
shall be obligated to register Restricted Stock pursuant to this Section 4 on two (2) occasions only; provided, however, that such obligation shall be deemed satisfied only when a registration statement covering all
shares of Restricted Stock specified in notices received as aforesaid for sale in accordance with the method of disposition specified by the requesting holders shall have become effective and, if such method of disposition is a firm commitment
underwritten public offering, all such shares shall have been sold pursuant thereto (not including shares eligible for sale pursuant to the underwriters’ over-allotment option) or it is closed or withdrawn at the request of the holders of
Restricted Stock (other than as a result of a material adverse change to the Company). 
 (c) The Company shall be entitled
to include in any registration statement referred to in this Section 4, shares of Common Stock to be sold by the Company for its own account, except as and to the extent that, in the good faith opinion of the managing underwriter, such
inclusion would adversely affect the marketing of the Restricted Stock to be sold. Except for registration statements on Forms S-4, S-8 or any successor thereto, the Company will not file with the Commission any other registration statement
with respect to its Common Stock, whether for its own account or that of other stockholders, from the date of receipt of a notice from requesting holders requesting sale pursuant to an underwritten offering pursuant to this Section 4
until the completion of the period of distribution of the registration contemplated thereby. 
 (d) If in the good faith
opinion of the managing underwriter the inclusion of all of the Restricted Stock requested to be registered under this Section would adversely affect the marketing of such shares, shares to be sold by the holders of Restricted Stock, if any, shall
be excluded only after any shares to be sold by other stockholders and the Company have been excluded, in such manner that the shares to be sold shall be allocated among the selling holders pro rata based on their ownership of Restricted
Stock. 
 5. Incidental Registration. If the Company at any time (other than pursuant to Section 4 or
Section 6) proposes to register any of its securities under the Securities Act for sale to the public, whether for its own account or for the account of other security holders or both (except with respect to registration statements on
Forms S-4, S-8 or another form not available for registering the Restricted Stock for sale to the public), each such time it will give written notice to all holders of outstanding Restricted Stock (and Preferred Shares) of its intention so to
do. Upon the written request of any such holder, received by the Company within 30 days after the giving of any such notice by the Company, to register any of its Restricted Stock, the Company will cause the Restricted Stock as to which
registration shall have been so requested to be included in the securities to be covered by the registration statement proposed to be filed by the Company, all to the extent requisite to permit the sale or other disposition by the holder of such
Restricted Stock so registered. In the event that any registration pursuant to this Section 5 shall be, in whole or in part, an underwritten public offering of Common Stock, the number of

  
 7 

 
shares of Restricted Stock to be included in such an underwriting may be reduced (pro rata among the requesting holders based upon the number of shares of Restricted Stock owned by such
holders) if and to the extent that the managing underwriter shall be of the opinion in good faith that such inclusion would adversely affect the marketing of the securities to be sold by the Company therein, provided further that in no event shall
the number of Restricted Stock included in the offering be reduced below thirty percent (30%) of the total number of securities included in such offering, unless such offering is the IPO, in which case the selling holders may be excluded
further if the underwriters make the determination described above and no other stockholder’s securities are included in such offering. In connection with any reduction in the number of shares pursuant to this Section 5, the shares
to be registered by the holders of Restricted Stock will only be reduced after all other stockholders’ shares are first reduced. There shall be no limitation on the number of registrations which may be requested and obtained under this
Section 5. 
 6. Registration on Form S-3. If at any time (i) the holders of Restricted Stock representing at
least 10% in interest of the total shares of Restricted Stock then outstanding request that the Company file a registration statement on Form S-3 or any successor thereto for a public offering of all or any portion of the shares of Restricted
Stock held by such requesting holder or holders, and (ii) the Company is a registrant entitled to use Form S-3 or any successor thereto to register such shares, then the Company shall use its reasonable best efforts to register under the
Securities Act on Form S-3 or any successor thereto, for public sale in accordance with the method of disposition specified in such notice, the number of shares of Restricted Stock specified in such notice; provided that the anticipated
aggregate offering price in each registration on Form S-3 shall exceed at least $1,000,000. Whenever the Company is required by this Section 6 to use its reasonable best efforts to effect the registration of Restricted Stock, each of the
procedures and requirements of Section 4 (including but not limited to the requirement that the Company notify all holders of Restricted Stock (including Preferred Shares) from whom notice has not been received and provide them with the
opportunity to participate in the offering) shall apply to such registration, provided, however, that there shall be no limitation on the number of registrations on Form S-3 which may be requested and obtained under this
Section 6, and provided, further, however, that the requirements contained in the first sentence of Section 4(a) shall not apply to any registration on Form S-3 which may be requested and obtained
under this Section 6. 
 Notwithstanding anything to the contrary in this Section 6, the Company shall not be required to effect
more than two (2) registrations pursuant to this Section 6 in any calendar year. 
 7. Registration Procedures. If
and whenever the Company is required by the provisions of Sections 4, 5 or 6 to use its reasonable best efforts to effect the registration of any shares of Restricted Stock under the Securities Act, the Company will, as
expeditiously as possible: 
 (a) prepare and file with the Commission a registration statement (which, in the case of an
underwritten public offering pursuant to Section 4, shall be on Form S-1 or other form of general applicability satisfactory to the managing underwriter selected as therein provided) with respect to such securities and use its reasonable
best efforts to cause such registration statement to become and remain effective for the period of the distribution contemplated thereby (determined as hereinafter provided); 

  
 8 

 (b) prepare and file with the Commission such amendments and supplements to such
registration statement and the prospectus used in connection therewith as may be necessary to keep such registration statement effective for the period specified in paragraph (a) above and comply with the provisions of the Securities Act with
respect to the disposition of all Restricted Stock covered by such registration statement in accordance with the sellers’ intended method of disposition set forth in such registration statement for such period; 

(c) furnish to each seller of Restricted Stock and to each underwriter such number of copies of the registration statement and
the prospectus included therein (including each preliminary prospectus) as such persons reasonably may request in order to facilitate the public sale or other disposition of the Restricted Stock covered by such registration statement; 

(d) use its reasonable best efforts to register or qualify the Restricted Stock covered by such registration statement under
the securities or “blue sky” laws of such jurisdictions as the sellers of Restricted Stock or, in the case of an underwritten public offering, the managing underwriter reasonably shall request, provided, however, that the Company shall not
for any such purpose be required to qualify generally to transact business as a foreign corporation in any jurisdiction where it is not so qualified or to consent to general service of process in any such jurisdiction; 

(e) use its reasonable best efforts to list the Restricted Stock covered by such registration statement with any securities
exchange or trading system and each securities exchange and trading system, if any, on which the Common Stock of the Company is then listed, or if the Restricted Stock is not listed, to list the Restricted Stock on the New York Stock Exchange or
Nasdaq, or other securities exchange or trading system acceptable to the Investors; 
 (f) provide a transfer agent and
registrar for all such Restricted Stock, not later than the effective date of such registration statement; 
 (g) immediately
notify each seller of Restricted Stock and each underwriter under such registration statement, at any time when a prospectus relating thereto is required to be delivered under the Securities Act, of the happening of any event of which the Company
has knowledge as a result of which the prospectus contained in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the
statements therein not misleading in light of the circumstances then existing; 
 (h) if the offering is underwritten and at
the request of any seller of Restricted Stock, use its reasonable best efforts to furnish on the date that Restricted Stock is delivered to the underwriters for sale pursuant to such registration: (i) an opinion dated such date of counsel
representing the Company for the purposes of such 

  
 9 

 
registration, addressed to the underwriters and to such seller, stating that such registration statement has become effective under the Securities Act and that (A) to the best knowledge of
such counsel, no stop order suspending the effectiveness thereof has been issued and no proceedings for that purpose have been instituted or are pending or contemplated under the Securities Act, (B) the registration statement, the related
prospectus and each amendment or supplement thereof do not contain any untrue statement of material fact or omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made,
not misleading and comply as to form in all material respects with the requirements of the Securities Act (except that such counsel need not express any opinion as to financial statements contained therein) and (C) to such other effects as
reasonably may be requested by counsel for the underwriters or by such seller or its counsel and (ii) a letter dated such date from the independent registered public accounting firm retained by the Company, addressed to the underwriters and to
such seller, stating that they are an independent registered public accounting firm within the meaning of the Securities Act and that, in the opinion of such accountants, the financial statements of the Company included in the registration statement
or the prospectus, free-writing prospectus, or any amendment or supplement thereof, comply as to form in all material respects with the applicable accounting requirements of the Securities Act, and such letter shall additionally cover such other
financial matters (including information as to the period ending no more than five (5) business days prior to the date of such letter) with respect to such registration as such underwriters reasonably may request; 

(i) make available for inspection by each seller of Restricted Stock, any underwriter participating in any distribution
pursuant to such registration statement, and any attorney, accountant or other agent retained by such seller or underwriter, all financial and other records, pertinent corporate documents and properties of the Company, and cause the Company’s
officers, directors and employees to supply all information reasonably requested by any such seller, underwriter, attorney, accountant or agent in connection with such registration statement; 

(j) advise each selling holder of Restricted Stock, promptly after it shall receive notice or obtain knowledge thereof, of the
issuance of any stop order by the Commission suspending the effectiveness of such registration statement or the initiation or threatening of any proceeding for such purpose and promptly use all reasonable efforts to prevent the issuance of any stop
order or to obtain its withdrawal if such stop order should be issued; 
 (k) cooperate with the selling holders of
Restricted Stock and the managing underwriters, if any, to facilitate the timely preparation and delivery of certificates representing Restricted Stock to be sold, such certificates to be in such denominations and registered in such names as such
holders or the managing underwriters may request at least two (2) business days prior to any sale of Restricted Stock; and 

  
 10 

 (l) permit any holder of Restricted Stock which holder, in the sole and exclusive
judgment, exercised in good faith, of such holder, might be deemed to be a controlling person of the Company, to participate in good faith in the preparation of such registration or comparable statement and to require the insertion therein of
material, furnished to the Company in writing, which in the reasonable judgment of such holder and its counsel should be included, subject to review by the Company and its counsel after consultation with such holder. 

For purposes of Section 7(a) and 7(b) and of Section 4(c), the period of distribution of Restricted Stock in a
firm commitment underwritten public offering shall be deemed to extend until each underwriter has completed the distribution of all securities purchased by it, and the period of distribution of Restricted Stock in any other registration shall be
deemed to extend until the earlier of the sale of all Restricted Stock covered thereby and 120 days after the effective date thereof. 

In connection with each registration hereunder, the sellers of Restricted Stock will furnish to the Company in writing such information with
respect to themselves and the proposed distribution by them as reasonably shall be necessary in order to assure compliance with federal and applicable state securities laws. 

In connection with each registration pursuant to Sections 4, 5 or 6 covering an underwritten public offering, the
Company and each seller agree to enter into a written agreement with the managing underwriter selected in the manner herein provided in such form and containing such provisions as are customary in the securities business for such an arrangement
between such underwriter and companies of the Company’s size and investment stature. 
 8. Expenses. All expenses incurred by
the Company in complying with Sections 4, 5 and 6, including, without limitation, all registration and filing fees, printing expenses, fees and disbursements of counsel and an independent registered public accounting firm
for the Company, fees and expenses (including counsel fees) incurred in connection with complying with state securities or “blue sky” laws, fees of the Financial Industry Regulatory Authority, transfer taxes, fees of transfer agents and
registrars, costs of insurance, and fees and disbursements of one counsel for the sellers of Restricted Stock, but excluding any Selling Expenses, are called “Registration Expenses.” All underwriting discounts and selling
commissions applicable to the sale of Restricted Stock are called “Selling Expenses.” 
 The Company will pay all
Registration Expenses in connection with each registration statement under Sections 4, 5 and 6. All Selling Expenses in connection with each registration statement under Sections 4, 5 or 6 shall be
borne by the participating sellers in proportion to the number of shares sold by each, or by such participating sellers other than the Company (except to the extent the Company shall be a seller) as they may agree. 

9. Indemnification and Contribution. 

(a) In the event of a registration of any of the Restricted Stock under the Securities Act pursuant to Sections 4,
5 or 6, the Company will indemnify and hold harmless each seller of such Restricted Stock thereunder, each underwriter of such Restricted Stock thereunder and each other person, if any, who controls such seller or

  
 11 

 
underwriter within the meaning of the Securities Act, against any losses, claims, damages or liabilities, joint or several, to which such seller, underwriter or controlling person may become
subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of or are based upon any untrue statement or alleged untrue statement of any material fact contained in
any registration statement under which such Restricted Stock was registered under the Securities Act pursuant to Sections 4, 5 or 6, any preliminary prospectus or final prospectus contained therein, or any amendment or
supplement thereof, or any free writing prospectus, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and
will reimburse each such seller, each such underwriter and each such controlling person for any legal or other expenses reasonably incurred by them in connection with investigating or defending any such loss, claim, damage, liability or action,
provided, however, that the Company will not be liable in any such case if and to the extent that any such loss, claim, damage or liability arises out of or is based upon an untrue statement or alleged untrue statement or omission or
alleged omission so made in conformity with information furnished by any such seller in writing specifically for use in such registration statement or prospectus. 

(b) In the event of a registration of any of the Restricted Stock under the Securities Act pursuant to Sections 4,
5 or 6, each seller of such Restricted Stock thereunder, severally and not jointly, will indemnify and hold harmless the Company, each person, if any, who controls the Company within the meaning of the Securities Act, each officer of
the Company who signs the registration statement, each director of the Company, each underwriter and each person who controls any underwriter within the meaning of the Securities Act, against all losses, claims, damages or liabilities, joint or
several, to which the Company or such officer, director, underwriter or controlling person may become subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof) arise out of
or are based upon any untrue statement or alleged untrue statement of any material fact contained in the registration statement under which such Restricted Stock was registered under the Securities Act pursuant to Sections 4, 5 or
6, any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereof, or arise out of or are based upon the omission or alleged omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and will reimburse the Company and each such officer, director, underwriter and controlling person for any legal or other expenses reasonably incurred by them in connection with investigating
or defending any such loss, claim, damage, liability or action, provided, however, that such seller will be liable hereunder in any such case if and only to the extent that any such loss, claim, damage or liability arises out of or is
based upon an untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with information pertaining to such seller, as such, furnished in writing to the Company by such seller specifically
for use in such registration statement or prospectus, and provided, further, however, that the liability of each seller hereunder shall be limited to the proportion of any such loss, claim, damage, liability or expense which is
equal to the proportion that the public offering price of the shares sold by such seller under such registration statement bears to the total public offering price of all securities sold thereunder, but not in any event to exceed the net proceeds
received by such seller from the sale of Restricted Stock covered by such registration statement. 

  
 12 

 (c) Promptly after receipt by an indemnified party hereunder of notice of the
commencement of any action, such indemnified party shall, if a claim in respect thereof is to be made against the indemnifying party hereunder, notify the indemnifying party in writing thereof, but the omission so to notify the indemnifying party
shall not relieve it from any liability which it may have to such indemnified party other than under this Section 9 and shall only relieve it from any liability which it may have to such indemnified party under this Section 9
if and to the extent the indemnifying party is prejudiced by such omission. In case any such action shall be brought against any indemnified party and it shall notify the indemnifying party of the commencement thereof, the indemnifying party shall
be entitled to participate in and, to the extent it shall wish, to assume and undertake the defense thereof with counsel reasonably satisfactory to such indemnified party, and, after notice from the indemnifying party to such indemnified party of
its election so to assume and undertake the defense thereof, the indemnifying party shall not be liable to such indemnified party under this Section 9 for any legal expenses subsequently incurred by such indemnified party in connection
with the defense thereof other than reasonable costs of investigation and of liaison with counsel so selected, provided, however, that, if the defendants in any such action include both the indemnified party and the indemnifying party
and the indemnified party shall have reasonably concluded that there may be reasonable defenses available to it which are different from or additional to those available to the indemnifying party or if the interests of the indemnified party
reasonably may be deemed to conflict with the interests of the indemnifying party, the indemnified party shall have the right to select a separate counsel and to assume such legal defenses and otherwise to participate in the defense of such action,
with the expenses and fees of such separate counsel and other expenses related to such participation to be reimbursed by the indemnifying party as incurred. 

(d) In order to provide for just and equitable contribution to joint liability under the Securities Act in any case in which
either (i) any holder of Restricted Stock exercising rights under this Agreement, or any controlling person of any such holder, makes a claim for indemnification pursuant to this Section 9 but it is judicially determined (by the
entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this
Section 9 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any such selling holder or any such controlling person in circumstances for which indemnification is
provided under this Section 9 then, and in each such case, the Company and such holder will contribute to the aggregate losses, claims, damages or liabilities to which they may be subject (after contribution from others) in such
proportion as is appropriate to reflect the relative fault of each of the parties in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other
relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined by reference to, among other things, whether the 

  
 13 

 
untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the indemnifying party or by the indemnified
party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided, however, that, in any such case, (A) no such holder will be required to
contribute any amount in excess of the net proceeds from the public offering of all such Restricted Stock sold by it pursuant to such registration statement; and (B) no person or entity guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation. 

10. Changes in Common Stock or Preferred Shares. If, and as often as, there is any change in the Common Stock or the Preferred Shares
by way of a stock split, stock dividend, combination or reclassification, or through a merger, consolidation, reorganization or recapitalization, or by any other means, appropriate adjustment shall be made in the provisions hereof so that the rights
and privileges granted hereby shall continue with respect to the Common Stock and the Preferred Shares as so changed. 
 11. Rule 144
Reporting. With a view to making available the benefits of certain rules and regulations of the Commission which may at any time permit the sale of the Restricted Stock to the public without registration, at all times after the first
registration statement covering a public offering of securities of the Company under the Securities Act shall have become effective, the Company agrees to: 

(a) make and keep current public information available, as those terms are understood and defined in Rule 144; 

(b) use its reasonable best efforts to file with the Commission in a timely manner all reports and other documents required of
the Company under the Securities Act and the Exchange Act; and 
 (c) furnish to each holder of Restricted Stock forthwith
upon request a written statement by the Company as to its compliance with the reporting requirements of such Rule 144 and of the Securities Act and the Exchange Act, a copy of the most recent annual or quarterly report of the Company, and such
other reports and documents so filed by the Company as such holder may reasonably request in availing itself of any rule or regulation of the Commission allowing such holder to sell any Restricted Stock without registration. 

12. Right of First Refusal. 

(a) Right of First Refusal. The Company shall not issue, sell or exchange, agree or obligate itself to issue, sell or
exchange, or reserve or set aside for issuance, sale or exchange, any (i) shares of Common Stock, (ii) any other equity security of the Company, including without limitation, Preferred Shares, (iii) any debt security of the Company
(other than debt with no equity feature) including without limitation, any debt security which by its terms is convertible into or exchangeable for any equity 

  
 14 

 
security of the Company, (iv) any security of the Company that is a combination of debt and equity, or (v) any option, warrant or other right to subscribe for, purchase or otherwise
acquire any such equity security or any such debt security of the Company, unless in each case the Company shall have first offered to sell such securities (the “Offered Securities”) to the Investors (each an
“Offeree” and collectively, the “Offerees”) as follows: Each Offeree shall have the right to purchase (x) that portion of the Offered Securities as the number of shares of Restricted Stock then held by such
Offeree bears to the total number of shares of Common Stock, on a fully diluted basis (the “Basic Amount”) and (y) such additional portion of the Offered Securities as such Offeree shall indicate it will purchase should the
other Offerees subscribe for less than their Basic Amounts (the “Undersubscription Amount”), at a price and on such other terms as shall have been specified by the Company in a writing delivered to such Offeree (the
“Offer”), which Offer shall contain the material terms of the Offer, the prospective other purchasers of such securities, and such Offeree’s Basic Amount and which Offer by its terms shall remain open and irrevocable for a
period of twenty (20) business days from receipt of the Offer. 
 (b) Notice of Acceptance. Notice of each
Offeree’s intention to accept, in whole or in part, any Offer made pursuant to Section 12(a) shall be evidenced by a writing signed by such Offeree and delivered to the Company prior to the end of the 20-business-day period of such
offer, setting forth such of the Offeree’s Basic Amount as such Offeree elects to purchase and, if such Offeree shall elect to purchase all of its Basic Amount, such Undersubscription Amount as such Offeree shall elect to purchase (the
“Notice of Acceptance”). If the Basic Amounts subscribed for by all Offerees are less than the total of all Basic Amounts of all Offerees, then each Offeree who has set forth Undersubscription Amounts in its Notice of Acceptance
shall be entitled to purchase, in addition to the Basic Amounts subscribed for, all Undersubscription Amounts it has subscribed for; provided, however, that should the Undersubscription Amounts subscribed for exceed the difference
between the total of all Basic Amounts and the Basic Amounts subscribed for (the “Available Undersubscription Amount”), each Offeree who has subscribed for any Undersubscription Amount shall be entitled to purchase only that portion
of the Available Undersubscription Amount as such Offeree’s Basic Amount bears to the total Basic Amount of all Offerees that has subscribed for any Undersubscription Amount, subject to rounding to the nearest whole share by the Board of
Directors to the extent it reasonably deems necessary. 
 (c) Conditions to Acceptances and Purchase. 

(i) Permitted Sales of Refused Securities. In the event that Notices of Acceptance are not given by the Offerees in respect of all the
Offered Securities, the Company shall have thirty (30) days from the expiration of the period set forth in Section 12(a) to close the sale of all or any part of such Offered Securities as to which a Notice of Acceptance has not been
given by the Offerees (the “Refused Securities”) to the Person or Persons specified in the Offer, but only for cash and otherwise in all respects upon terms and conditions, including, without limitation, unit price and interest
rates, which are no more favorable to such other Person or Persons or less favorable to the Company than those set forth in the Offer. 

  
 15 

 (ii) Reduction in Amount of Offered Securities. In the event the Company shall propose to
sell less than all the Refused Securities (any such sale to be in the manner and on the terms specified in Section 12(c)(i) above), then each Offeree may, at its sole option and in its sole discretion, reduce the number of, or other
units of the Offered Securities specified in its respective Notices of Acceptance to an amount which shall be not less than the amount of the Offered Securities which the Offeree elected to purchase pursuant to Section 12(b) multiplied
by a fraction, (i) the numerator of which shall be the amount of Offered Securities which the Company actually proposes to sell, and (ii) the denominator of which shall be the amount of all Offered Securities. In the event that any Offeree
so elects to reduce the number or amount of Offered Securities specified in its respective Notices of Acceptance, the Company may not sell or otherwise dispose of more than the reduced amount of the Offered Securities until such securities have
again been offered to the Offerees in accordance with Section 12(a). 
 (iii) Closing. Upon the closing, which shall
include full payment to the Company, of the sale to such other Person or Persons of all or less than all the Refused Securities, the Offerees shall purchase from the Company, and the Company shall sell to the Offerees, the number of Offered
Securities specified in the Notices of Acceptance, as reduced pursuant to Section 12(c)(ii) if the Offerees have so elected, upon the terms and conditions specified in the Offer. The purchase by the Offerees of any Offered Securities is
subject in all cases to the preparation, execution and delivery by the Company and the Offerees of a purchase agreement relating to such Offered Securities reasonably satisfactory in form and substance to the Offerees and their respective counsel.

 (d) Further Sale. In each case, any Offered Securities not purchased by the Offerees or other Person or Persons in
accordance with Section 12(c) may not be sold or otherwise disposed of until they are again offered to the Offerees under the procedures specified in Sections 12(a), 12(b) and 12(c). 

(e) Termination of Right of First Refusal. The rights of the Offerees under this Section 12 shall terminate
immediately prior to, but subject to, the consummation of a Qualified Initial Public Offering or a Deemed Liquidation Event (as defined in the Certificate of Incorporation); provided, however, that the rights of the Investors pursuant to this
Section 12 may be waived as to all of such Investors by the Requisite Vote, and any such waiver shall be binding on all Investors, even if any of such Investors does not execute such waiver and irrespective of whether one or more
Investors participates in the purchase of the Offered Securities, and provided further that notwithstanding any waiver of any of the provisions of this Section 12, in the event any Major Investor actually purchases Offered Securities in
any offering by the Company, then each other Major Investor shall be permitted to participate in such offering on a pro rata basis (based on the level of participation of the Major Investor purchasing the largest portion of such Major
Investor’s Basic Amount), in accordance with the other provisions (including the notice and election periods) set forth in Section 12. 

(f) Exception. The rights of the Investors under this Section 12 shall not apply to Exempt Securities as
defined in Article IV, Section 5D of the Certificate of Incorporation. 

  
 16 

 13. Covenants of the Company. 

(a) Affirmative Covenants of the Company Other Than Reporting Requirements. Without limiting any other covenants and
provisions hereof, and except to the extent the following covenants and provisions of this Section 13(a) are waived by vote or written consent of the Requisite Vote or the Board of Directors, which includes a majority of the Preferred
Directors, the Company covenants and agrees that until the consummation of a Qualified Initial Public Offering it will perform and observe the following covenants and provisions, and will cause each Subsidiary, if and when such Subsidiary exists, to
perform and observe such of the following covenants and provisions as are applicable to such Subsidiary: 
 (i) Payment of Taxes and
Trade Debt. Pay and discharge, and cause each Subsidiary to pay and discharge, all taxes, assessments and governmental charges or levies imposed upon it or upon its income, profits or business, or upon any properties belonging to it, prior to
the date on which penalties attach thereto, and all lawful claims which, if unpaid, might become a lien or charge upon any properties of the Company or any Subsidiary; provided, however, that neither the Company nor any Subsidiary
shall be required to pay any such tax, assessment, charge, levy or claim which is being contested in good faith and by appropriate proceedings if the Company or any Subsidiary shall have set aside on its books sufficient reserves, if any, with
respect thereto. Pay and cause each Subsidiary to pay, when due, or in conformity with customary trade terms, all lease obligations, all trade debt, and all other Indebtedness incident to the operations of the Company or its Subsidiaries, except
such as are being contested in good faith and by proper proceedings if the Company or Subsidiary concerned shall have set aside on its books sufficient reserves, if any, with respect thereto. 

(ii) Maintenance of Insurance; Indemnification. Maintain, and cause each Subsidiary to maintain, insurance (including Directors’
and Officers’ insurance) with responsible and reputable insurance companies or associations in such amounts and covering such risks as is customarily carried by companies engaged in similar businesses and owning similar properties in the same
general areas in which the Company or such Subsidiary operates, but in any event in amounts sufficient to prevent the Company or Subsidiary from becoming a co-insurer. In addition, the Company shall enter into and use its best efforts to at all
times maintain indemnification agreements substantially in the form previously approved by the Board of Directors, with each of its directors to indemnify such directors to the maximum extent permissible under applicable law. 

(iii) Successor Indemnification. If the Company or any of its successors or assignees consolidates with or merges into any other Person
and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the obligations of the Company with
respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bylaws, its Certificate of Incorporation, or elsewhere, as the case may
be. 

  
 17 

 (iv) Insurance. The Company shall use its commercially reasonable efforts to obtain,
within ninety (90) days of the date hereof, from a financially sound and reputable insurer Directors and Officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially
reasonable efforts to cause such insurance policy to be maintained until such time as the Board of Directors determines that such insurance should be discontinued. 

(v) Preservation of Corporate Existence. Preserve and maintain, and, unless the Company deems it not to be in its best interests,
cause each Subsidiary to preserve and maintain, its corporate existence, rights, franchises and privileges in the jurisdiction of its incorporation, and qualify and remain qualified, and cause each Subsidiary to qualify and remain qualified, as a
foreign corporation in each jurisdiction in which such qualification is necessary or desirable in view of its business and operations or the ownership or lease of its properties. Secure, preserve and maintain, and cause each Subsidiary to secure,
preserve and maintain, all licenses and other rights to use Intellectual Property Rights owned or possessed by it and deemed by the Company to be necessary to the conduct of its business and the businesses of its Subsidiaries, taken as a whole. 

(vi) Compliance with Laws. Comply, and cause each Subsidiary to comply, with the requirements of all applicable laws, rules,
regulations and orders of any governmental authority. 
 (vii) Inspection; Confidentiality. 

(A) Permit, upon reasonable request and notice, each Major Investor or any agents or representatives thereof, to examine and make copies of
and extracts from the books of account of, and visit and inspect the properties of the Company and any Subsidiary, to discuss the affairs, finances and accounts of the Company and any Subsidiary with any of its officers, directors or Key Employees
and independent accountants, and consult with and advise the management of the Company and any Subsidiary as to their affairs, finances and accounts, all at reasonable times during normal business hours. 

(B) Subject to the disclosure of information of a non-technical nature, including financial information, which such Investor discloses to its
partners and/or shareholders generally, and subject to disclosures required by law or court order, each Investor agrees that it will keep confidential and will not disclose or divulge any confidential, proprietary or secret information which such
Investor may obtain from the Company pursuant to financial statements, reports and other materials submitted by the Company as required hereunder, or pursuant to visitation or inspection rights granted hereunder unless such information is or becomes
known to the Investor from a source other than the Company or is or becomes publicly known, or unless so required by law or legal process, or unless the Company gives its written consent to such Investor’s release of such information, except
that no such written consent shall be required (and the Investor shall be free to release such information to such recipient) if such information is to be provided to the Investor’s counsel or accountant, or to an officer, director, member,
partner or prospective limited partner of such Investor, provided that the Investor shall inform the recipient of the confidential nature of such information, and shall instruct the recipient to treat the information as confidential. 

  
 18 

 (viii) Keeping of Records and Books of Account. Keep, and cause each Subsidiary to keep,
adequate records and books of account in which complete entries will be made in accordance with generally accepted accounting principles consistently applied, reflecting all financial transactions of the Company and any Subsidiary, and in which, for
each fiscal year, all proper reserves for depreciation, depletion, returns of merchandise, obsolescence, amortization, taxes, bad debts and other purposes in connection with its business shall be made. 

(ix) Maintenance of Properties. Maintain and preserve, and cause each Subsidiary to maintain and preserve, all of its properties and
assets, necessary for the proper conduct of its business, in good repair, working order and condition, ordinary wear and tear excepted. 

(x) Compliance with ERISA. Comply, and cause each Subsidiary to comply, with all minimum funding requirements applicable to any
pension, employee benefit plans or employee contribution plans which are subject to ERISA or to the Code or any similar foreign laws, and comply, and cause each Subsidiary to comply, in all other material respects with the provisions of ERISA and
the Code and any similar foreign laws, and the rules and regulations thereunder, which are applicable to any such plan. The Company shall not permit any event or condition to exist which could permit any such plan to be terminated under
circumstances which would cause the lien provided for in Section 4068 of ERISA or any similar foreign laws to attach to the assets of the Company or any Subsidiary. 

(xi) Bylaws. At all times maintain provisions in the Bylaws or Certificate of Incorporation of the Company indemnifying all directors
against liability to the maximum extent permitted under the laws of the State of Delaware. 
 (xii)
Non-Competition, Non-Solicitation and Non-Disclosure Agreements. The Company will obtain a duly executed Non-Competition, Non-Solicitation and Non-Disclosure Agreement (which will endure for a minimum
of one year post-employment) substantially in the form previously approved by the Board of Directors from each Key Employee. 
 (xiii)
New Developments. Where reasonably practicable, cause all technological developments, patentable or unpatentable inventions, discoveries or improvements by the Company’s or any Subsidiary’s officers or employees to be documented in
accordance with the appropriate professional standards, cause all officers, employees and consultants of the Company or any Subsidiary, to execute Nondisclosure and Developments Agreements substantially in the form previously approved by the Board
of Directors in favor of the Company or any Subsidiary and, where possible and deemed by management to be commercially appropriate based on the advice of legal counsel and other considerations, to file and prosecute United States and foreign patent
or copyright applications relating to and protecting such developments on behalf of the Company or any Subsidiary. 

  
 19 

 (xiv) Reserved. 

(xv) Expenses of Directors. Promptly reimburse in full, each director of the Company who is not an employee of the Company for all of
his reasonable out-of-pocket expenses incurred in attending each meeting of the Board of Directors or any committee thereof. In addition, the Company shall promptly
reimburse in full, any Major Investor Observer (as defined below) appointed by ProQuest Investments IV, L.P. for all of his reasonable out-of-pocket expenses incurred in
attending each meeting of the Board of Directors. 
 (xvi) Stock Vesting. All stock options and other stock equivalents issued after
the date of this Agreement to employees, directors, consultants and other service providers shall be subject to vesting over a four-year period as follows: (a) twenty-five percent (25%) of such stock shall vest at the end of the first year
following the earlier of the date of issuance or such person’s services commencement date with the Company, and (b) seventy-five percent (75%) of such stock shall vest in equal monthly installments over the remaining three
(3) years. With respect to any shares of stock purchased by any such person, the Company’s repurchase option shall provide that upon such person’s termination of employment or service with the Company, with or without cause, the
Company or its assignee shall have the option to purchase at cost any unvested shares of stock held by such person. 
 (xvii) Founder
Observer. So long as Kenneth Gall (the “Founder”) holds at least 2,000 shares of the outstanding Common Stock (as adjusted for stock splits, stock dividends, recapitalizations and the like), the Founder may appoint one
(1) representative to serve as an observer (the “Founders Observer”) of the Board of Directors. The Founder may remove the Founders Observer or appoint a new Founders Observer if a vacancy in such position occurs for any reason
by delivery of a written notice to the Secretary of the Company. 
 (xviii) Major Investor Observers. Each Major Investor may
appoint one (1) representative to serve as an observer of the Board of Directors (each a “Major Investor Observer” and together with the Founders Observer, the “Existing Observers”). 

The Company or the applicable members of the Board of Directors will give the Existing Observers oral or written notice of each meeting of the
Board of Directors (whether annual or special) at the same time and in the same manner as oral or written notice is given to the applicable members of the Board of Directors (which notice may be waived by each Existing Observer). Notwithstanding the
foregoing, if an Existing Observer attends (or, in the case of a telephonic meeting, listens by telephone to) any such meeting of the Board of Directors, then such Existing Observer shall be deemed to have had proper notice of such meeting.
Notwithstanding anything contained herein to the contrary, the failure of an Existing Observer to be given notice of a meeting of the Board of Directors pursuant to the immediately preceding two sentences or to attend such meeting shall not in any
way affect the authority of the Board of Directors to have or to adopt resolutions at such meeting or the legitimacy of any actions taken by the Board of Directors at such meeting. Subject to the foregoing, the Company will permit the Existing
Observers to attend (or, in the case of a telephonic meeting, to listen by telephone to) each meeting of the Board of Directors as non-voting observers. The Company shall provide the Existing Observers all written materials and other information
(including copies of meeting minutes) given to the members of the Board of Directors in connection with any such meeting at 

  
 20 

 
the same time as such information is delivered to the members of the Board of Directors and, if an Existing Observer does not attend (or, in the case of a telephonic meeting, does not listen by
telephone to) a meeting of the Board of Directors, such Existing Observer will be entitled, upon request, to receive the written minutes or an oral summary of the meeting from the Secretary of the Company. Prior to attending or listening to any
meeting of the Board of Directors or obtaining any documents or summaries of such meetings, each Existing Observer shall agree in writing to be bound by the same duties of confidentiality, good faith and loyalty as if such Observer were a director
of the Company. If the Company takes any action by written consent of the Board of Directors in lieu of a meeting of the Board of Directors, then the Company shall give prompt written notice of such action to the Existing Observers. 

(xix) Committee Membership. In the event that the Board of Directors forms an executive committee or a compensation committee or
committees thereof, the director appointed to the Board of Directors by ProQuest shall be provided the opportunity, but shall not have any obligation, to serve as a member of each such committee. 

(xx) Proprietary Information and Inventions Agreement. The Company shall require all employees and consultants to execute and deliver
a Proprietary Information and Inventions Agreement substantially in the form previously approved by the Board of Directors. 

(b) Negative Covenants of the Company. Without limiting any other covenants and provisions hereof, the Company covenants
and agrees that, until the consummation of a Qualified Initial Public Offering or, while this Agreement remains effective, it will comply with and observe the following covenants and provisions, and will cause each Subsidiary, if and when such
Subsidiary exists, to comply with and observe such of the following covenants and provisions as are applicable to such Subsidiary, and will not, without the vote or written consent of the Requisite Vote or the Board of Directors, including the
approval of a majority of the Preferred Directors: 
 (i) Restrictions on Indebtedness. Unless otherwise approved by the Board of
Directors, create, incur, assume or suffer to exist, or permit any Subsidiary to create, incur, assume or suffer to exist, any liability with respect to Indebtedness for money borrowed which exceeds, in the aggregate, $250,000. 

(ii) Assumptions or Guaranties of Indebtedness of Other Persons. Assume, guarantee, endorse or otherwise become directly or
contingently liable on, or permit any Subsidiary to assume, guarantee, endorse or otherwise become directly or contingently liable on (including, without limitation, liability by way of agreement, contingent or otherwise, to purchase, to provide
funds for payment, to supply funds to or otherwise invest in the debtor or otherwise to assure the creditor against loss) any Indebtedness of any other Person, except for guaranties by endorsement of negotiable instruments for deposit or collection
in the ordinary course of business, and except for the guaranties of the permitted obligations of any wholly-owned Subsidiary. 

  
 21 

 (iii) Ownership of Subsidiaries. Purchase or hold beneficially any stock, other
securities or evidences of Indebtedness in, or make any investment in any other Person, excluding a wholly-owned Subsidiary of the Company. 

(iv) Dealings with Affiliates and Others. Other than as contemplated by this Agreement, enter into, after the date of this Agreement,
any transaction, including, without limitation, any loans or extensions of credit or royalty agreements, with any officer, director or affiliate of the Company or any Subsidiary or any member of their respective immediate families or any corporation
or other entity directly or indirectly affiliated with one or more of such officers, directors or members of their immediate families unless such transaction is approved in advance by a majority of the disinterested members of the Board of
Directors. 
 (v) Maintenance of Ownership of Subsidiaries. Sell or otherwise dispose of any shares of capital stock of any
Subsidiary, except to another Subsidiary, or permit any Subsidiary to issue, sell or otherwise dispose of any shares of its capital stock or the capital stock of any Subsidiary, except to the Company or another Subsidiary; provided,
however, that the Company may liquidate, merge or consolidate any Subsidiary or Subsidiaries into or with itself, provided that the Company is the surviving entity, or into or with another Subsidiary or Subsidiaries. 

(c) Reporting Requirements. Until the consummation of a Qualified Initial Public Offering, the Company will furnish to (1) each
Major Investor and, (2) with respect to (i), (ii) and (iii) below only, each other Investor requesting such information: 

(i) Monthly Reports: as soon as available and in any event within 30 days after the end of each calendar month, unaudited consolidated
financial statements (including balance sheet, statement of income, and statement of cash flows) of the Company and its Subsidiaries as of the end of such month and for the period commencing at the end of the previous fiscal year and ending with the
end of such month; 
 (ii) Quarterly Reports: as soon as available and in any event within 45 days after the end of the first,
second and third quarterly accounting periods in each fiscal year of the Company, a consolidated balance sheet of the Company as of the end of each such quarterly period, and a consolidated statement of income and a consolidated statement of cash
flows of the Company for such period and for the current fiscal year to date, prepared in accordance with generally accepted accounting principles consistently applied (except as noted therein); 

(iii) Annual Reports: as soon as available and in any event within 120 days after the end of each fiscal year of the Company, a copy
of the annual audit report for such year for the Company and its Subsidiaries, including therein consolidated balance sheets of the Company and its Subsidiaries as of the end of such fiscal year and consolidated statements of income and of the
Company and its Subsidiaries for such fiscal year, setting forth in each case in comparative form the corresponding figures for the preceding fiscal year, all such consolidated statements to be prepared in accordance with generally accepted
accounting principles consistently applied (except as noted therein) by such independent registered public accounting firm of recognized national standing approved by a majority of the Board of Directors; 

  
 22 

 (iv) Capitalization Tables: as soon as available, but in any event within forty-five
(45) days after the end of each quarter of each fiscal year of the Company, a statement showing the number of shares of each class and series of capital stock and securities convertible into or exercisable for shares of capital stock
outstanding at the end of the period, the Common Stock issuable upon conversion or exercise of any outstanding securities convertible or exercisable for Common Stock and the exchange ratio or exercise price applicable thereto, and issuance, if any,
all in sufficient detail as to permit the Major Investors to calculate their respective percentage equity ownership in the Company, and certified by the chief financial officer or chief executive officer of the Company as being true, complete and
correct; 
 (v) Budgets: as soon as available after approval by the Board of Directors and in any event within 30 days prior to the
end of each year at the Company, monthly operating budgets for the forthcoming fiscal year and any revisions or updates thereto; 
 (vi)
Business Plan: as soon as available after approval by the Board of Directors and in any event within 30 days prior to the end of each year at the Company, a business plan for the forthcoming fiscal year and any revisions or updates thereto;
and 
 (vii) Other Information: such other information respecting the business, properties or the condition or operations, financial
or other, of the Company or any of its Subsidiaries as any such Investor may from time to time reasonably request. 
 The holders of
Restricted Stock hereby covenant and agree that all of the information disclosed to such holders pursuant to the provisions of this Section 14(c) shall be treated in accordance with Section 14(a)(vii) of this Agreement. 

14. Representations and Warranties of the Company. The Company represents and warrants as follows: 

(a) The execution, delivery and performance of this Agreement by the Company has been duly authorized by all requisite
corporate action and will not violate any provision of law, any order of any court or other agency of government, the existing Certificate of Incorporation or Bylaws of the Company or any provision of any indenture, agreement or other instrument to
which it or any or its properties or assets is bound, conflict with, result in a breach of or constitute (with due notice or lapse of time or both) a default under any such indenture, agreement or other instrument or result in the creation or
imposition of any lien, charge or encumbrance of any nature whatsoever upon any of the properties or assets of the Company. 

(b) This Agreement has been duly executed and delivered by the Company and constitutes the legal, valid and binding obligation
of the Company, enforceable in accordance with its terms. 

  
 23 

 15. Miscellaneous. 

(a) All covenants and agreements contained in this Agreement by or on behalf of any of the parties hereto shall bind and inure
to the benefit of the respective successors and assigns of the parties hereto (including without limitation transferees of any Preferred Shares or Restricted Stock), whether so expressed or not, provided, however, that registration rights conferred
herein on the holders of Preferred Shares, Conversion Shares or Restricted Stock shall only inure to the benefit of a transferee of Preferred Shares, Conversion Shares or Restricted Stock if (i) there is transferred to such transferee at least
10,000 shares of Restricted Stock and/or Preferred Shares originally issued pursuant to that certain Series A Purchase Agreement, dated April 29, 2005, that certain Series B Purchase Agreement, dated April 7, 2006, that certain Series C
Purchase Agreement, dated September 5, 2007, that certain Series C Purchase Agreement, dated March 14, 2008, that certain Series D Purchase Agreement, dated February 17, 2010, as amended, that certain Series D-1 Convertible Preferred
Stock and Warrant Purchase Agreement, dated March 8, 2011, or the Series E Purchase Agreement to the direct or indirect transferor of such transferee, (ii) there is transferred to such transferee all shares of Restricted Stock held by such
transferor if transferred to a single transferee or (iii) such transferee is a subsidiary, parent, partner, limited partner, retired partner, member, retired member, shareholder, family member, trust for the benefit of a holder hereto or
affiliate of a party hereto. 
 (b) All notices, requests, consents and other communications hereunder shall be in writing
and shall be delivered in person, mailed by certified or registered mail, return receipt requested, or sent by facsimile, addressed as follows: 

if to the Company: 
 Mevion
Medical Systems, Inc. 
 Attn: Chief Executive Officer 

300 Foster Street 
 Littleton, MA
01460 
 or at such other address as shall be designated by the Company in a written notice to the other parties complying as to delivery with the terms of
this Section, with a copy (which shall not constitute notice) to: 
 Mitchell S. Bloom, Esq. 

Goodwin Procter LLP 
 53 State
Street 
 Boston, MA 02109 

Fax: 617-523-1231 
 or if to an
Investor, at the address set forth on Exhibit A hereto; 
 if to any subsequent holder of Preferred Shares, Conversion Shares or
Restricted Stock, to it at such address as may have been furnished to the Company in writing by such holder; 

  
 24 

 or, in any case, at such other address or addresses as shall have been furnished in writing to the Company (in
the case of a holder of Preferred Shares, Conversion Shares or Restricted Stock) or to the holders of Preferred Shares, Conversion Shares or Restricted Stock (in the case of the Company) in accordance with the provisions of this paragraph. 

(c) This Agreement shall be governed by and construed in accordance with the General Corporation Law of the State of Delaware
as to matters within the scope thereof, and as to all other matters shall be governed by and construed in accordance with the internal laws of the Commonwealth of Massachusetts, without regard to its principles of conflicts of laws. 

(d) This Agreement may not be amended or modified, and no provision hereof may be waived, without the Requisite Vote;
provided, that any amendment, modification and/or waiver of any provision hereof, so consented to by the Requisite Vote, shall be binding on all holders of Restricted Stock. 

(e) This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered
and be valid and effective for all purposes. 
 (f) The obligations of the Company to register shares of Restricted Stock
under Sections 4, 5 or 6 shall terminate upon the earliest to occur of: 
 (i) the closing of a Deemed Liquidation
Event, as such term is defined in the Certificate of Incorporation; or 
 (ii) such time as Rule 144 or another similar exemption under the
Securities Act is available for the sale of all such Investor’s shares without limitation during a three-month period without registration. 

(g) In connection with the IPO of the Company, each Investor hereby agrees that it will not, without the prior written consent
of the managing underwriter, during the period commencing on the date of the final prospectus relating to the IPO, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty
(180) days, or such other period as may be requested by the Company or an underwriter to accommodate regulatory restrictions on (1) the publication or other distribution of research reports and (2) analyst recommendations and
opinions, including, but not limited to, the restrictions contained in FINRA Rule 2711(f)(4) or NYSE Rule 472(f)(4), or any successor provisions or amendments thereto), (i) lend; offer; pledge; sell; contract to sell; sell any option or
contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable
or exchangeable (directly or indirectly) for Common Stock (whether such shares or any such securities are then owned by the 

  
 25 

 
Investor or are thereafter acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such
securities, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of this Section 15(g) shall not
apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall be applicable to the Investors only if all officers, directors and all stockholders individually owning more than one percent (1%) of the
Company’s outstanding Common Stock (after giving effect to conversion into Common Stock of all outstanding Preferred Stock) are subject to the same restrictions. provided, that the foregoing provisions shall only be applicable to the
Investors if all stockholders, officers and directors are treated similarly with respect to any release prior to the termination of the lock-up period (including any extension thereof) such that if any such persons are released all Investors shall
also be released to the same extent on a pro rata basis. The underwriters in connection with the IPO are intended third-party beneficiaries of this Section 15(g) and shall have the
right, power, and authority to enforce the provisions hereof as though they were a party hereto. Each Investor further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with the IPO that are
consistent with this Section 15(g) or that are necessary to give further effect thereto. 
 (h) Notwithstanding
the provisions of Section 4(a), the Company’s obligation to file a registration statement, or cause such registration statement to become and remain effective, shall be suspended for a period not to exceed 60 days in any 12 month
period if there exists at the time material non-public information relating to the Company which, in the reasonable opinion of the Company, should not be disclosed. 

(i) The Company shall not grant to any third party any registration rights to demand a registration of shares of the
Company’s capital stock unless (A) the Company first receives written consent by the holders of at least a majority of the Restricted Shares or (B) such registration rights are subordinate to the registration rights of the Investors
as set forth in this Agreement. 
 (j) If any provision of this Agreement shall be held to be illegal, invalid or
unenforceable, such illegality, invalidity or unenforceability shall attach only to such provision and shall not in any manner affect or render illegal, invalid or unenforceable any other provision of this Agreement, and this Agreement shall be
carried out as if any such illegal, invalid or unenforceable provision were not contained herein. 
 16. Waiver of Right of First
Refusal. All rights of Investors under Section 12 of the Third Amended and Restated Investor Rights Agreement are hereby waived with respect to the issuance of the Series E Preferred Stock pursuant to the Series E Purchase Agreement,
including without limitation the right of first refusal and the right to notice. This waiver shall be binding upon all parties to the Third Amended and Restated Investor Rights Agreement upon the execution of this Agreement by the Company and the
holders of a majority of the Restricted Stock (as defined in the Third Amended and Restated Investor Rights Agreement) pursuant to Section 15(d) of the Third Amended and Restated Investor Rights Agreement. 

  
 26 

 [Remainder of Page Intentionally Left Blank] 

  
 27 

 IN WITNESS WHEREOF, the undersigned has executed this Fourth Amended and Restated Investor Rights
Agreement as of the date set forth above. 
  

			
	MEVION MEDICAL SYSTEMS, INC.
		
	By:	 	/s/ Joseph Jachinowski
	Name: Joseph Jachinowski
	Title: Chief Executive Officer

 [Signature Page to Fourth Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

			
	PROQUEST INVESTMENTS IV, L.P.
	By:	 	 ProQuest Associates IV LLC
 its General
Partner

		
	By:	 	/s/ Pasquale DeAngelis
	Name: Pasquale DeAngelis
	Title: Managing Member

 [Signature Page to Fourth Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

			
	CHL MEDICAL PARTNERS III, L.P.
	By:	 	 CHL Medical Partners III, LLC
 its General
Partner

		
	By:	 	/s/ Myles D. Greenberg
		 	Name: Myles D. Greenberg
		 	Title: Vice President
	
	CHL MEDICAL PARTNERS III SIDE FUND, L.P.
	By:	 	 CHL Medical Partners III, LLC
 its General
Partner

		
	By:	 	/s/ Myles D. Greenberg
		 	Name: Myles D. Greenberg
		 	Title: Vice President

 [Signature Page to Fourth Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

					
	STORRINGTON INDUSTRIES LIMITED
		
	By:	 	/s/ Michael Begg
		 	Name:	 	Michael Begg
		 	Title:	 	Managing Director

 [Signature Page to Fourth Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

	
	 /s/ Robert N. Wilson

Robert N. Wilson

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

			
	CHLS (STILL RIVER) LLC
		
	By:	 	/s/ Peter D’Angelo
	Name:	 	Peter D’Angelo
	Title:	 	President, Caxton Health Holdings, LLC, Managing Member

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

			
	Z-3 INVESTORS, LLC
		
	By:	 	/s/ Marc Buntaine
	Name:	 	Marc Buntaine
	Title:	 	General Manager

	
	
	/s/ Marc Buntaine
	Marc Buntaine
	
	/s/ Catherine S. Buntaine
	Catherine S. Buntaine

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor Rights
Agreement as of the date set forth above. 
 VENROCK HEALTHCARE CAPITAL PARTNERS, L.P. 

By its General Partner, VHCP Management, LLC 
  

			
	By:	 	/s/ Anders Hove
	Name:	 	Anders Hove
	Title:	 	Managing Member

 VHCP CO-INVESTMENT HOLDINGS, LLC 

By its Manager, VHCP Management, LLC 

			
		
	By:	 	/s/ Anders Hove
	Name:	 	Anders Hove
	Title:	 	Managing Member

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

			
	WHITESTONE CAPITAL, LLC
		
	By:	 	/s/ James R. Utaski
	Name:	 	James R. Utaski
	Title:	 	General Manager

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

			
	PE SRS, LLC
		
	By:	 	/s/ Frank Kee Cohen
	Name:	 	Frank Kee Cohen
	Title:	 	 

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

	
	 /s/ Daniel Tully

Daniel Tully

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

	
	 /s/ Robert F. Johnston

The Robert F. Johnston Living Trust

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

	
	 /s/ James Jacobson

James Jacobson

 PENSON FINANCIAL SERVICES CUST FOR 

JAMES JACOBSON ROTH IRA CONVERSION 

			
		
	By:	 	/s/ Michael Fragh
	Name:	 	Michael Fragh
	Title:	 	Senior Associate

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 IN WITNESS WHEREOF, the undersigned have executed this Fourth Amended and Restated Investor
Rights Agreement as of the date set forth above. 
  

	
	 /s/ Paul Volcker

Paul Volcker

  
 [Signature Page to Fourth
Amended and Restated Investor Rights Agreement] 

 MEVION MEDICAL SYSTEMS, INC. 

INSTRUMENT OF ACCESSION 

The undersigned,
                        , as a condition precedent to becoming the owner or holder of record of
                     (            ) shares of the Series
                         Convertible Preferred Stock, par value $0.01 per share, of Mevion Medical Systems,
Inc., a Delaware corporation (the “Company”), hereby agrees to become an Investor under that certain Fourth Amended and Restated Investor Rights Agreement dated as of January 12, 2012, as the same may be amended, restated or
otherwise modified from time to time (the “Investor Rights Agreement”) by and among the Company and certain other stockholders of the Company. This Instrument of Accession shall take effect and shall become an integral part of, and
the undersigned shall become a party to and bound by, said Investor Rights Agreement immediately upon execution and delivery to the Company of this Instrument of Accession. 

IN WITNESS WHEREOF, this INSTRUMENT OF ACCESSION has been duly executed by or on behalf of the undersigned, as a sealed instrument under the
laws of the State of Delaware, as of the date below written. 
  

			
	 Signature:
  

 

 
			
	(Print Name) 	 	 
		
	Address:	 	
		
	 	 	 
		
	 	 	 

 
			
		
	Date: 	 	 

 
			
		
	Accepted:	 	
	
	MEVION MEDICAL SYSTEMS, INC.

 
			
		
	By: 	 	 
	 Name: Joseph Jachinowski
 Title:
Chief Executive Officer

 
			
		
	Date: 	 	 

 Exhibit A 

Name and Address of Investors 
 ProQuest
Investments IV, L.P. 
 90 Nassau Street, 5th Floor 

Princeton, NJ 08542 
 CHLS (Still River) LLC 

500 Park Ave., New York, NY 10022 
 Attn: Rob Wedeking 

Phone: 212-593-7700 
 Fax: 212-371-1046 

Marc Buntaine 
 Catherine S. Buntaine 

5 Wildwood Drive, Sherborn, MA 01770 
 Phone: 617-395-8807 

Fax: 617-395-8807 
 American Shared Hospital Service 

Four Embarcadero Center 
 Suite 3700 

San Francisco, CA 94111-4107 
 Phone: 415-788-5300 

Fax: 415-788-5660 
 Z-3 Investors, LLC 

5 Wildwood Dr. Sherborn, MA 01770 
 Phone: 617-395-8807 

Fax: 617-395-8807 
 Varian Medical Systems, Inc. 

3100 Hansen Way 
 Palo Alto, CA 94304 

Attn: Marketing Manager, Emerging Technologies 
 Phone:
650-424-5809 
 Fax: 650-493-3377 
 Seneca Capital LP 

Seneca Capital International Ltd. Seneca Capital II LP 
 590
Madison Avenue, 28th floor 
 New York, NY 10022 
 Attn: 

Phone: 
 Fax: 

 Venrock Healthcare Capital Partners, L.P. 

VHCP Co-Investment Holdings, LLC 
 530 Fifth Avenue 

22nd Floor 

New York, NY 10036 
 Attn: Sherman Souther 

Phone: 
 Fax: 

CHL Medical Partners III, L.P. 
 CHL Medical Partners III Side
Fund, L.P. 
 1055 Washington Blvd 
 Stamford, CT 06901 

Attn: Myles Greenberg 
 Phone: 

Fax: 
 Storrington Industries Limited 

Water Lane 
 Storrington 

West Sussex, England 
 RH20 3 EA 

Phone: 
 Fax: 

GC&H Investments, LLC 
 Cooley Godward Kronish LLP 

101 California Street 5th Floor San Francisco, CA 94111-5800 

Attn: Jim Kindler 
 Phone: 415-693-2000 

Fax: 415-693-2222 
 Robert N. Wilson 

40 Mechanic Street 
 New Hope, PA 18939 

Phone: 
 Fax: 

Daniel Tully 
 398 S. Beach Road 

Hobe Sound, FL 33455 

 The Robert L. Johnston Living Trust 

155 Lambert Drive 
 Princeton, NJ 08540 

Penson Financial Services Cust for James 
 Jacobson Roth IRA
conversion 
 1981 Marcus Avenue 
 Lake Success, NY 11042 

James Jacobson 
 3 E. 69th Street, Apt. 7A 
 New York, NY 10021 

Paul Volcker 
 610
5th Avenue 
 Room 42 

New York, NY 10020 
 PE SRS, LLC 

c/o Oppenheimer & Co., Inc. 
 300 Madison Avenue, 4th Floor 
 New York, NY 10017 

Whitestone Capital, LLC 
 47 Hulfish Street, Ste. 550C 

Princeton, NJ 09542 

 Exhibit B 

Indemnification Agreement

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00235-of-00352.parquet"}]]